###################################################################################################################################################################
#Enrichment results using 'Biological Process from Gene Ontology (GO)', created by dcGO Enrichment at 16/06/2016 14:18:30 (day/month/year hour:min:sec)
#Citation: Fang H, Gough J. (2012) dcGO: database of domain-centric ontologies on functions, phenotypes, diseases and more. Nucleic Acids Res (PubMed ID: 23161684)
###################################################################################################################################################################
#
#'GroupID' column: group id (by default 'Group' for single group);
#'GO ID' column: the identifier of ontological terms;
#'GO term' column: the name of ontological terms;
#'xxxx (four levels)' column: term specificity (only appear when using slim version of the ontology; 1 for highly general, 2 for general, 3 for specific, and 4 for highly specific);
#'Z-score' column: Z-score being calculated based on hypergeometric distribution;
#'P-value' column: P-value being calculated based on hypergeometric distribution;
#'FDR' column: FDR used to assess the statistical significance of term enrichments;
#'#Domains (Overlaps|Group|Term|Background)' column: the number of domains, i.e., 'Overlaps' for the number of domains in the input group but also being annotated by the term; 'Group' for the number of domains in the input group (also annotatable by the ontology); 'Term' for the number of domains being annotated by the term; 'Backgroud' for the number of domains that are annotatable by the ontology.
#'Annotated domains' column: a list of semicolon-separated domains in the input group but also being annotated by the term.
#
GroupID	GO ID	GO term	PFAM slim (four levels)	Z-score	P-value	FDR	#Domains (Overlaps|Group|Term|Background)	Annotated domains
Group	GO:0023051	regulation of signaling	1	10.94	1.53e-21	1.25e-18	92|275|441|3527	PF00019;PF00020;PF00027;PF00040;PF00057;PF00059;PF00063;PF00086;PF00093;PF00094;PF00097;PF00122;PF00130;PF00168;PF00169;PF00179;PF00240;PF00270;PF00271;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00515;PF00564;PF00605;PF00611;PF00618;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00884;PF00969;PF01030;PF01302;PF01391;PF01392;PF01403;PF01412;PF01437;PF01485;PF01562;PF01585;PF01699;PF01753;PF01833;PF02145;PF02148;PF02177;PF02214;PF02218;PF02377;PF02434;PF02865;PF02891;PF03165;PF03226;PF03920;PF04868;PF06920;PF07525;PF07645;PF07653;PF07679;PF08232;PF09289;PF09324;PF09379;PF09380;PF10409;PF10608;PF12548;PF12763;PF12783;PF12796;PF12924;PF13405;PF13637;PF13639;PF13716;PF13855;PF13920;PF14324;PF14429
Group	GO:0048583	regulation of response to stimulus	1	10.02	5.26e-19	2.13e-16	95|275|503|3527	PF00019;PF00020;PF00027;PF00040;PF00057;PF00059;PF00063;PF00086;PF00093;PF00094;PF00097;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00240;PF00270;PF00271;PF00307;PF00373;PF00400;PF00452;PF00515;PF00564;PF00605;PF00611;PF00618;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00884;PF00969;PF01030;PF01217;PF01302;PF01391;PF01392;PF01403;PF01412;PF01437;PF01476;PF01485;PF01562;PF01585;PF01602;PF01753;PF01833;PF02145;PF02148;PF02177;PF02214;PF02218;PF02377;PF02434;PF02865;PF02891;PF03165;PF03226;PF03920;PF04868;PF06733;PF06920;PF07525;PF07534;PF07645;PF07653;PF07679;PF07686;PF08232;PF08246;PF09289;PF09379;PF09380;PF10409;PF12548;PF12763;PF12796;PF12924;PF13405;PF13637;PF13639;PF13716;PF13855;PF13920;PF14324;PF14429
Group	GO:0032879	regulation of localization	1	10.35	1.23e-18	3.33e-16	72|275|318|3527	PF00019;PF00020;PF00027;PF00040;PF00045;PF00059;PF00063;PF00076;PF00085;PF00086;PF00093;PF00097;PF00122;PF00130;PF00168;PF00169;PF00254;PF00258;PF00307;PF00349;PF00373;PF00400;PF00413;PF00435;PF00452;PF00564;PF00611;PF00618;PF00622;PF00667;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00884;PF00928;PF00969;PF01030;PF01044;PF01217;PF01302;PF01391;PF01392;PF01403;PF01437;PF01471;PF01562;PF01833;PF02145;PF02185;PF02214;PF04810;PF07546;PF07645;PF07651;PF07653;PF07679;PF07686;PF07690;PF08246;PF10409;PF12548;PF12697;PF12796;PF13405;PF13637;PF13716;PF13855;PF13903;PF13920
Group	GO:0010646	regulation of cell communication	1	10.22	1.97e-18	3.99e-16	74|275|336|3527	PF00019;PF00020;PF00027;PF00040;PF00057;PF00059;PF00063;PF00086;PF00093;PF00122;PF00130;PF00168;PF00169;PF00179;PF00240;PF00270;PF00271;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00618;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00884;PF00969;PF01030;PF01302;PF01391;PF01392;PF01403;PF01437;PF01485;PF01585;PF01699;PF01833;PF02145;PF02214;PF02218;PF02434;PF02865;PF02891;PF03165;PF03226;PF03920;PF04868;PF07525;PF07645;PF07653;PF07679;PF09289;PF09379;PF09380;PF10409;PF10608;PF12548;PF12763;PF12796;PF13405;PF13637;PF13639;PF13716;PF13855;PF13920;PF14324
Group	GO:0048519	negative regulation of biological process	1	9.37	7.77e-18	1.26e-15	112|275|681|3527	PF00019;PF00024;PF00057;PF00076;PF00086;PF00093;PF00097;PF00122;PF00130;PF00168;PF00169;PF00179;PF00226;PF00240;PF00241;PF00254;PF00258;PF00270;PF00271;PF00307;PF00349;PF00350;PF00373;PF00385;PF00400;PF00435;PF00452;PF00515;PF00564;PF00605;PF00611;PF00622;PF00642;PF00651;PF00667;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00789;PF00884;PF00969;PF01030;PF01088;PF01302;PF01335;PF01391;PF01392;PF01403;PF01426;PF01477;PF01562;PF01585;PF01602;PF01699;PF01753;PF01833;PF01909;PF02145;PF02148;PF02177;PF02181;PF02201;PF02214;PF02865;PF02891;PF03165;PF03226;PF03920;PF05033;PF05773;PF06297;PF06733;PF06741;PF07525;PF07546;PF07645;PF07653;PF07679;PF07686;PF08210;PF08246;PF09058;PF09289;PF09379;PF09380;PF10409;PF10524;PF10608;PF11934;PF12047;PF12548;PF12697;PF12763;PF12796;PF12906;PF12924;PF13086;PF13405;PF13639;PF13716;PF13733;PF13854;PF13855;PF13920;PF14259;PF14324
Group	GO:0019538	protein metabolic process	1	8.78	1.34e-16	1.81e-14	128|275|869|3527	PF00019;PF00027;PF00040;PF00045;PF00057;PF00059;PF00063;PF00076;PF00082;PF00085;PF00094;PF00097;PF00122;PF00130;PF00133;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00254;PF00258;PF00270;PF00271;PF00373;PF00385;PF00400;PF00413;PF00415;PF00432;PF00452;PF00515;PF00534;PF00535;PF00557;PF00564;PF00583;PF00605;PF00611;PF00622;PF00651;PF00667;PF00675;PF00688;PF00702;PF00754;PF00757;PF00780;PF00789;PF00884;PF00899;PF00989;PF01030;PF01088;PF01302;PF01336;PF01391;PF01426;PF01433;PF01471;PF01485;PF01546;PF01562;PF01663;PF01753;PF01841;PF02008;PF02148;PF02177;PF02185;PF02201;PF02214;PF02225;PF02434;PF02518;PF02824;PF02865;PF02891;PF03133;PF03165;PF03256;PF04137;PF04389;PF04810;PF04818;PF04868;PF05020;PF05021;PF05033;PF05193;PF05773;PF07645;PF07653;PF07679;PF07686;PF07687;PF07707;PF07973;PF08246;PF08662;PF08736;PF08926;PF09379;PF09380;PF09409;PF10409;PF11717;PF12548;PF12697;PF12796;PF12894;PF12895;PF12906;PF12924;PF13344;PF13405;PF13519;PF13589;PF13637;PF13639;PF13733;PF13831;PF13832;PF13848;PF13855;PF13920;PF14324
Group	GO:0043412	macromolecule modification	1	8.69	2.04e-15	2.37e-13	99|275|602|3527	PF00019;PF00027;PF00063;PF00076;PF00085;PF00094;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00240;PF00254;PF00258;PF00270;PF00271;PF00373;PF00385;PF00400;PF00415;PF00432;PF00515;PF00534;PF00535;PF00557;PF00564;PF00583;PF00605;PF00611;PF00622;PF00651;PF00667;PF00688;PF00754;PF00757;PF00780;PF00899;PF00989;PF01030;PF01088;PF01189;PF01302;PF01426;PF01485;PF01585;PF01663;PF01753;PF01841;PF02008;PF02148;PF02177;PF02185;PF02201;PF02214;PF02225;PF02434;PF02518;PF02865;PF02891;PF03133;PF03165;PF03256;PF04389;PF04408;PF04762;PF04810;PF04818;PF04868;PF05033;PF05773;PF06464;PF07645;PF07653;PF07679;PF07707;PF08210;PF08736;PF08926;PF09379;PF09380;PF10409;PF11717;PF12047;PF12697;PF12796;PF12894;PF12895;PF12906;PF12924;PF13344;PF13637;PF13639;PF13733;PF13831;PF13832;PF13855;PF13920;PF14324
Group	GO:0065008	regulation of biological quality	1	8.54	4.48e-15	4.54e-13	101|275|628|3527	PF00019;PF00024;PF00027;PF00057;PF00059;PF00063;PF00076;PF00082;PF00085;PF00093;PF00094;PF00122;PF00130;PF00149;PF00153;PF00168;PF00169;PF00240;PF00241;PF00254;PF00270;PF00271;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00583;PF00611;PF00618;PF00622;PF00642;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00780;PF00928;PF01044;PF01217;PF01302;PF01336;PF01391;PF01392;PF01403;PF01433;PF01437;PF01477;PF01496;PF01553;PF01562;PF01602;PF01699;PF01826;PF01841;PF02145;PF02148;PF02177;PF02181;PF02214;PF02218;PF02225;PF02865;PF03165;PF04389;PF06367;PF06371;PF06733;PF06741;PF06920;PF07645;PF07653;PF07679;PF07686;PF07690;PF07707;PF07973;PF08246;PF08736;PF08742;PF09379;PF09380;PF10409;PF10608;PF11971;PF12710;PF12763;PF12796;PF12924;PF13246;PF13405;PF13637;PF13716;PF13855;PF13903;PF14259;PF14429
Group	GO:0048518	positive regulation of biological process	1	8.18	3.81e-14	3.43e-12	103|275|667|3527	PF00019;PF00020;PF00024;PF00027;PF00040;PF00053;PF00057;PF00059;PF00063;PF00076;PF00086;PF00093;PF00122;PF00130;PF00133;PF00168;PF00169;PF00179;PF00240;PF00241;PF00270;PF00271;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00515;PF00564;PF00605;PF00611;PF00618;PF00642;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00884;PF00969;PF00989;PF01030;PF01302;PF01335;PF01391;PF01392;PF01403;PF01426;PF01437;PF01476;PF01485;PF01562;PF01585;PF01699;PF01833;PF02177;PF02181;PF02185;PF02198;PF02218;PF02434;PF02518;PF02865;PF02891;PF03165;PF04868;PF05790;PF06367;PF06371;PF06733;PF07525;PF07534;PF07645;PF07653;PF07679;PF07686;PF08210;PF08246;PF08313;PF08788;PF09816;PF10409;PF10524;PF11717;PF11971;PF12548;PF12697;PF12763;PF12796;PF12924;PF13086;PF13405;PF13637;PF13639;PF13716;PF13855;PF13920;PF14259;PF14324
Group	GO:0007399	nervous system development	1	8.35	1.25e-13	1.01e-11	73|275|397|3527	PF00019;PF00024;PF00052;PF00053;PF00057;PF00063;PF00122;PF00130;PF00168;PF00169;PF00254;PF00307;PF00373;PF00400;PF00415;PF00435;PF00452;PF00501;PF00515;PF00564;PF00611;PF00618;PF00651;PF00688;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00884;PF01030;PF01044;PF01391;PF01392;PF01403;PF01437;PF01562;PF01833;PF02145;PF02148;PF02177;PF02181;PF02263;PF02377;PF02865;PF02891;PF03165;PF06367;PF06371;PF06741;PF07525;PF07531;PF07645;PF07653;PF07679;PF07686;PF08506;PF08736;PF08788;PF09379;PF09380;PF10409;PF10524;PF10608;PF12548;PF12796;PF12924;PF13385;PF13716;PF13855;PF13903;PF14324
Group	GO:0031323	regulation of cellular metabolic process	1	7.79	1.54e-13	1.14e-11	121|275|867|3527	PF00019;PF00020;PF00027;PF00057;PF00059;PF00063;PF00076;PF00086;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00254;PF00270;PF00271;PF00307;PF00349;PF00373;PF00385;PF00400;PF00415;PF00435;PF00452;PF00501;PF00515;PF00564;PF00605;PF00611;PF00618;PF00642;PF00651;PF00688;PF00757;PF00778;PF00780;PF00789;PF00899;PF00989;PF01030;PF01088;PF01302;PF01336;PF01352;PF01391;PF01392;PF01403;PF01412;PF01426;PF01437;PF01477;PF01585;PF01751;PF01753;PF01833;PF02008;PF02145;PF02148;PF02177;PF02198;PF02201;PF02218;PF02377;PF02518;PF02770;PF02771;PF02865;PF02891;PF02985;PF03165;PF03920;PF04408;PF04762;PF04818;PF04868;PF05033;PF05773;PF06733;PF06920;PF07525;PF07528;PF07531;PF07645;PF07653;PF07679;PF07686;PF07973;PF08210;PF08313;PF08662;PF08711;PF08788;PF09379;PF09380;PF09816;PF10524;PF10608;PF11717;PF11934;PF11971;PF12047;PF12697;PF12763;PF12796;PF12895;PF12924;PF13086;PF13405;PF13639;PF13716;PF13831;PF13832;PF13854;PF13855;PF13920;PF14259;PF14324;PF14429
Group	GO:0051128	regulation of cellular component organization	1	8.38	2.22e-13	1.39e-11	65|275|333|3527	PF00019;PF00024;PF00059;PF00063;PF00086;PF00130;PF00168;PF00169;PF00179;PF00226;PF00241;PF00254;PF00270;PF00271;PF00307;PF00373;PF00400;PF00435;PF00452;PF00515;PF00611;PF00618;PF00622;PF00651;PF00688;PF00754;PF00757;PF00780;PF01030;PF01044;PF01088;PF01302;PF01391;PF01392;PF01403;PF01437;PF01562;PF01833;PF02008;PF02145;PF02148;PF02181;PF02185;PF02518;PF03165;PF06367;PF06371;PF06733;PF07645;PF07651;PF07653;PF07679;PF07686;PF07707;PF08210;PF08736;PF09379;PF09380;PF10409;PF12796;PF12895;PF12906;PF13637;PF13855;PF13920
Group	GO:0051239	regulation of multicellular organismal process	1	8.12	3.03e-13	1.76e-11	78|275|448|3527	PF00019;PF00020;PF00024;PF00027;PF00059;PF00063;PF00076;PF00086;PF00093;PF00122;PF00130;PF00168;PF00169;PF00240;PF00254;PF00258;PF00271;PF00307;PF00373;PF00385;PF00400;PF00435;PF00452;PF00515;PF00564;PF00605;PF00611;PF00618;PF00622;PF00642;PF00651;PF00667;PF00688;PF00689;PF00690;PF00702;PF00778;PF00780;PF00884;PF00969;PF01391;PF01392;PF01403;PF01437;PF01562;PF01699;PF01753;PF01833;PF02177;PF02181;PF02198;PF02214;PF02377;PF02518;PF02865;PF03165;PF03226;PF04818;PF06367;PF06371;PF06741;PF07525;PF07531;PF07645;PF07653;PF07679;PF07686;PF08246;PF10409;PF10524;PF10608;PF12548;PF12763;PF12796;PF12924;PF13405;PF13716;PF13855
Group	GO:0050793	regulation of developmental process	1	8.16	3.68e-13	1.99e-11	73|275|405|3527	PF00019;PF00024;PF00057;PF00063;PF00076;PF00086;PF00093;PF00130;PF00168;PF00169;PF00179;PF00241;PF00254;PF00270;PF00271;PF00307;PF00373;PF00385;PF00400;PF00435;PF00452;PF00515;PF00564;PF00605;PF00611;PF00618;PF00622;PF00642;PF00651;PF00688;PF00778;PF00780;PF00884;PF01391;PF01392;PF01403;PF01437;PF01562;PF01753;PF01833;PF02177;PF02181;PF02185;PF02198;PF02377;PF02518;PF02865;PF03165;PF03226;PF04818;PF06367;PF06371;PF07525;PF07531;PF07645;PF07679;PF07686;PF08246;PF08736;PF09379;PF09380;PF10409;PF10524;PF12548;PF12763;PF12796;PF12906;PF12924;PF13405;PF13637;PF13716;PF13855;PF14259
Group	GO:0080090	regulation of primary metabolic process	1	7.44	1.61e-12	8.19e-11	118|275|861|3527	PF00019;PF00020;PF00024;PF00027;PF00057;PF00059;PF00063;PF00076;PF00086;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00349;PF00373;PF00385;PF00400;PF00415;PF00435;PF00452;PF00501;PF00515;PF00564;PF00605;PF00611;PF00618;PF00642;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF00789;PF00899;PF00989;PF01030;PF01088;PF01302;PF01335;PF01336;PF01352;PF01391;PF01392;PF01403;PF01412;PF01426;PF01437;PF01585;PF01751;PF01753;PF01833;PF02008;PF02145;PF02148;PF02177;PF02198;PF02201;PF02218;PF02377;PF02865;PF02891;PF02985;PF03165;PF03920;PF04408;PF04762;PF04818;PF04868;PF05033;PF05773;PF06733;PF06920;PF07525;PF07528;PF07531;PF07645;PF07653;PF07679;PF07686;PF07973;PF08210;PF08313;PF08662;PF08711;PF08788;PF09379;PF09380;PF09816;PF10524;PF11717;PF11934;PF11971;PF12047;PF12697;PF12763;PF12796;PF12895;PF12924;PF13086;PF13405;PF13639;PF13716;PF13831;PF13832;PF13854;PF13855;PF13920;PF14259;PF14324;PF14429
Group	GO:0065009	regulation of molecular function	1	7.78	3.59e-12	1.62e-10	70|275|396|3527	PF00019;PF00020;PF00027;PF00057;PF00063;PF00076;PF00085;PF00086;PF00097;PF00130;PF00168;PF00169;PF00179;PF00226;PF00240;PF00254;PF00258;PF00307;PF00373;PF00400;PF00415;PF00452;PF00564;PF00611;PF00618;PF00622;PF00667;PF00688;PF00757;PF00778;PF00780;PF00899;PF01302;PF01335;PF01391;PF01392;PF01403;PF01412;PF01437;PF01585;PF01909;PF02145;PF02148;PF02177;PF02377;PF02434;PF02865;PF03165;PF04868;PF06920;PF07525;PF07645;PF07653;PF07679;PF08246;PF08736;PF09324;PF09379;PF09380;PF10608;PF11934;PF11971;PF12796;PF12924;PF13405;PF13716;PF13855;PF13903;PF13920;PF14429
Group	GO:0033036	macromolecule localization	1	7.61	1.42e-11	5.77e-10	64|275|354|3527	PF00019;PF00052;PF00053;PF00057;PF00063;PF00076;PF00122;PF00130;PF00168;PF00169;PF00226;PF00240;PF00241;PF00270;PF00271;PF00307;PF00350;PF00373;PF00400;PF00432;PF00435;PF00501;PF00515;PF00564;PF00611;PF00675;PF00683;PF00688;PF00778;PF00928;PF01044;PF01217;PF01302;PF01391;PF01392;PF01465;PF01477;PF01602;PF02145;PF02865;PF02985;PF03765;PF03810;PF04695;PF04810;PF05193;PF07645;PF07653;PF07679;PF08389;PF08506;PF09058;PF09379;PF09380;PF10409;PF10608;PF12710;PF12763;PF12796;PF13246;PF13405;PF13637;PF13855;PF14259
Group	GO:0006928	cellular component movement	1	7.46	5.74e-11	2.03e-09	56|275|296|3527	PF00019;PF00024;PF00045;PF00052;PF00053;PF00057;PF00063;PF00130;PF00168;PF00169;PF00226;PF00241;PF00307;PF00373;PF00400;PF00413;PF00435;PF00515;PF00611;PF00618;PF00688;PF00754;PF00757;PF00778;PF00928;PF00989;PF01030;PF01217;PF01302;PF01403;PF01437;PF01471;PF01562;PF01602;PF01833;PF02148;PF02177;PF02181;PF02185;PF02214;PF03133;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07686;PF09379;PF10409;PF11971;PF12924;PF13405;PF13855;PF14429
Group	GO:0051641	cellular localization	1	6.96	1.70e-10	4.75e-09	77|275|494|3527	PF00019;PF00027;PF00053;PF00063;PF00076;PF00085;PF00122;PF00130;PF00149;PF00153;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00350;PF00400;PF00432;PF00435;PF00452;PF00515;PF00611;PF00618;PF00622;PF00651;PF00675;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00928;PF00989;PF01044;PF01217;PF01302;PF01391;PF01392;PF01403;PF01412;PF01465;PF01602;PF02138;PF02145;PF02177;PF02181;PF02865;PF02985;PF03810;PF04695;PF04810;PF05193;PF07645;PF07651;PF07653;PF07679;PF07707;PF08389;PF08506;PF09324;PF10608;PF11971;PF12763;PF12783;PF12796;PF12924;PF13246;PF13385;PF13405;PF13637;PF13850;PF13855;PF13920
Group	GO:0032990	cell part morphogenesis	1	7.33	3.11e-10	8.16e-09	44|275|210|3527	PF00024;PF00052;PF00053;PF00063;PF00130;PF00168;PF00169;PF00271;PF00307;PF00400;PF00415;PF00435;PF00515;PF00611;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF01030;PF01044;PF01391;PF01403;PF01437;PF01833;PF02148;PF02177;PF02263;PF02377;PF03133;PF03165;PF06741;PF07645;PF07653;PF07679;PF08736;PF10162;PF10524;PF10608;PF12796;PF12924;PF13716;PF13855
Group	GO:0060255	regulation of macromolecule metabolic process	1	6.46	5.87e-10	1.49e-08	112|275|868|3527	PF00019;PF00020;PF00024;PF00027;PF00057;PF00059;PF00076;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00349;PF00373;PF00385;PF00400;PF00415;PF00435;PF00452;PF00515;PF00564;PF00605;PF00642;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF00789;PF00899;PF00989;PF01030;PF01088;PF01302;PF01335;PF01336;PF01352;PF01391;PF01392;PF01403;PF01426;PF01437;PF01477;PF01585;PF01751;PF01753;PF01833;PF02008;PF02145;PF02148;PF02177;PF02198;PF02201;PF02218;PF02377;PF02865;PF02891;PF02985;PF03165;PF03920;PF04408;PF04762;PF04818;PF04868;PF05033;PF05773;PF06464;PF06733;PF07525;PF07528;PF07531;PF07645;PF07653;PF07679;PF07686;PF07973;PF08210;PF08246;PF08313;PF08662;PF08711;PF08788;PF09379;PF09380;PF09816;PF10409;PF10524;PF11717;PF11934;PF12047;PF12763;PF12796;PF12895;PF12924;PF13086;PF13405;PF13639;PF13716;PF13831;PF13832;PF13854;PF13855;PF13920;PF14259;PF14324
Group	GO:0042221	response to chemical stimulus	1	6.46	1.42e-09	3.20e-08	87|275|615|3527	PF00019;PF00020;PF00027;PF00040;PF00045;PF00052;PF00053;PF00057;PF00059;PF00063;PF00076;PF00085;PF00093;PF00122;PF00130;PF00149;PF00153;PF00168;PF00169;PF00179;PF00226;PF00240;PF00258;PF00270;PF00271;PF00307;PF00349;PF00373;PF00400;PF00413;PF00435;PF00452;PF00501;PF00515;PF00583;PF00605;PF00622;PF00651;PF00667;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00969;PF00989;PF01030;PF01370;PF01391;PF01392;PF01403;PF01437;PF01471;PF01554;PF01833;PF01909;PF02145;PF02148;PF02177;PF02218;PF02263;PF02518;PF02865;PF03165;PF06920;PF07525;PF07645;PF07653;PF07679;PF07686;PF07690;PF08246;PF08416;PF08736;PF10409;PF10524;PF12796;PF12924;PF13405;PF13639;PF13716;PF13848;PF13855;PF14429
Group	GO:0051171	regulation of nitrogen compound metabolic process	1	6.42	1.59e-09	3.49e-08	90|275|647|3527	PF00019;PF00020;PF00027;PF00063;PF00076;PF00097;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00270;PF00271;PF00307;PF00385;PF00400;PF00435;PF00515;PF00564;PF00605;PF00611;PF00618;PF00642;PF00651;PF00688;PF00757;PF00780;PF00899;PF00989;PF01030;PF01088;PF01302;PF01336;PF01352;PF01391;PF01392;PF01403;PF01412;PF01426;PF01437;PF01585;PF01751;PF01753;PF01833;PF02008;PF02145;PF02177;PF02198;PF02201;PF02518;PF02865;PF02891;PF03165;PF03920;PF04408;PF04762;PF04818;PF05033;PF06733;PF06920;PF07528;PF07531;PF07645;PF07653;PF07679;PF08210;PF08313;PF08711;PF08788;PF09816;PF10524;PF11717;PF11934;PF11971;PF12047;PF12796;PF12895;PF12924;PF13086;PF13405;PF13716;PF13831;PF13832;PF13854;PF13855;PF13920;PF14259;PF14324;PF14429
Group	GO:0006950	response to stress	1	6.22	3.61e-09	7.52e-08	95|275|709|3527	PF00019;PF00020;PF00024;PF00027;PF00040;PF00045;PF00057;PF00059;PF00063;PF00076;PF00082;PF00085;PF00093;PF00094;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00350;PF00373;PF00400;PF00413;PF00435;PF00452;PF00501;PF00515;PF00534;PF00564;PF00605;PF00618;PF00622;PF00651;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00780;PF00899;PF00969;PF00989;PF01030;PF01033;PF01302;PF01336;PF01391;PF01471;PF01476;PF01477;PF01826;PF01833;PF01841;PF01909;PF02145;PF02177;PF02263;PF02518;PF02824;PF02865;PF02891;PF04389;PF05773;PF05790;PF06733;PF06920;PF07534;PF07645;PF07653;PF07679;PF07686;PF08246;PF08742;PF10391;PF10409;PF11717;PF12697;PF12842;PF12924;PF13086;PF13405;PF13589;PF13639;PF13716;PF13848;PF13855;PF14324;PF14429
Group	GO:0009605	response to external stimulus	1	6.53	4.52e-09	8.96e-08	56|275|330|3527	PF00019;PF00020;PF00027;PF00052;PF00053;PF00059;PF00063;PF00076;PF00082;PF00122;PF00149;PF00271;PF00307;PF00373;PF00400;PF00435;PF00501;PF00564;PF00618;PF00622;PF00651;PF00688;PF00689;PF00690;PF00702;PF00754;PF00778;PF00780;PF00899;PF00969;PF01391;PF01392;PF01403;PF01437;PF01833;PF02145;PF02148;PF02177;PF02518;PF02824;PF02865;PF03165;PF05773;PF06920;PF07645;PF07679;PF07686;PF08246;PF08736;PF10409;PF10524;PF12796;PF12924;PF13637;PF13855;PF14429
Group	GO:0007163	establishment or maintenance of cell polarity	1	7.30	4.70e-09	9.08e-08	25|275|88|3527	PF00052;PF00053;PF00057;PF00063;PF00130;PF00169;PF00307;PF00373;PF00400;PF00435;PF00564;PF00651;PF00778;PF01302;PF02181;PF06367;PF06371;PF07653;PF07679;PF08736;PF09379;PF09380;PF10608;PF13855;PF14259
Group	GO:0030030	cell projection organization	1	6.61	6.11e-09	1.13e-07	46|275|246|3527	PF00019;PF00024;PF00052;PF00053;PF00063;PF00130;PF00168;PF00169;PF00307;PF00373;PF00400;PF00415;PF00435;PF00515;PF00611;PF00618;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF01030;PF01044;PF01391;PF01403;PF01437;PF01833;PF02148;PF02177;PF02263;PF02377;PF03133;PF03165;PF06741;PF07645;PF07653;PF07679;PF08736;PF10162;PF10524;PF10608;PF12796;PF12924;PF13716;PF13855
Group	GO:0007154	cell communication	1	6.03	1.05e-08	1.85e-07	92|275|691|3527	PF00019;PF00020;PF00027;PF00057;PF00059;PF00063;PF00076;PF00082;PF00085;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00564;PF00605;PF00611;PF00618;PF00622;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00884;PF00899;PF00928;PF00969;PF00989;PF01030;PF01044;PF01217;PF01302;PF01370;PF01391;PF01392;PF01403;PF01412;PF01437;PF01465;PF01562;PF01602;PF01833;PF02140;PF02141;PF02145;PF02177;PF02185;PF02214;PF02377;PF02518;PF02759;PF02824;PF02865;PF03165;PF03920;PF05773;PF05790;PF07525;PF07645;PF07653;PF07679;PF07686;PF07690;PF07707;PF08246;PF08506;PF10409;PF10608;PF11971;PF12548;PF12763;PF12796;PF12924;PF13639;PF13716;PF13855
Group	GO:0023052	signaling	1	5.91	2.16e-08	3.66e-07	87|275|648|3527	PF00019;PF00020;PF00027;PF00057;PF00059;PF00063;PF00076;PF00085;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00307;PF00349;PF00373;PF00400;PF00435;PF00452;PF00564;PF00605;PF00611;PF00618;PF00622;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00884;PF00928;PF00969;PF00989;PF01030;PF01044;PF01217;PF01302;PF01370;PF01391;PF01392;PF01403;PF01412;PF01437;PF01465;PF01562;PF01602;PF01833;PF02140;PF02141;PF02145;PF02177;PF02185;PF02214;PF02377;PF02518;PF02759;PF02865;PF03165;PF05790;PF07525;PF07645;PF07653;PF07679;PF07686;PF07690;PF07707;PF08246;PF08506;PF10409;PF10608;PF11971;PF12548;PF12763;PF12796;PF12924;PF13639;PF13716;PF13855
Group	GO:0000902	cell morphogenesis	1	6.27	2.41e-08	3.92e-07	47|275|265|3527	PF00019;PF00024;PF00052;PF00053;PF00063;PF00130;PF00168;PF00169;PF00307;PF00373;PF00400;PF00415;PF00435;PF00515;PF00611;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF01030;PF01044;PF01391;PF01392;PF01403;PF01437;PF01833;PF02148;PF02177;PF02263;PF02377;PF03133;PF03165;PF06741;PF06920;PF07645;PF07653;PF07679;PF08736;PF10162;PF10524;PF10608;PF12796;PF12924;PF13716;PF13855
Group	GO:0051234	establishment of localization	1	5.70	4.28e-08	6.69e-07	99|275|785|3527	PF00019;PF00027;PF00040;PF00053;PF00057;PF00059;PF00063;PF00076;PF00085;PF00122;PF00130;PF00149;PF00153;PF00168;PF00169;PF00179;PF00226;PF00241;PF00254;PF00270;PF00271;PF00307;PF00349;PF00350;PF00400;PF00432;PF00435;PF00452;PF00501;PF00515;PF00611;PF00618;PF00622;PF00651;PF00675;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00928;PF00989;PF01033;PF01145;PF01217;PF01302;PF01391;PF01412;PF01426;PF01465;PF01477;PF01496;PF01553;PF01554;PF01562;PF01602;PF01699;PF01833;PF02138;PF02145;PF02177;PF02214;PF02225;PF02770;PF02865;PF02985;PF03765;PF03810;PF04389;PF04695;PF04810;PF05193;PF07546;PF07645;PF07651;PF07653;PF07679;PF07686;PF07690;PF07707;PF08246;PF08389;PF08506;PF09324;PF11971;PF12710;PF12763;PF12783;PF12796;PF12924;PF13246;PF13385;PF13405;PF13519;PF13637;PF13850;PF13855;PF14259
Group	GO:0051674	localization of cell	1	6.15	5.59e-08	8.41e-07	42|275|229|3527	PF00019;PF00024;PF00045;PF00052;PF00053;PF00057;PF00063;PF00130;PF00226;PF00241;PF00307;PF00373;PF00413;PF00435;PF00515;PF00611;PF00618;PF00688;PF00754;PF00757;PF00778;PF01030;PF01403;PF01437;PF01471;PF01562;PF01833;PF02148;PF02185;PF02214;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07686;PF10409;PF11971;PF13855;PF14429
Group	GO:0009790	embryo development	1	6.02	6.00e-08	8.86e-07	50|275|299|3527	PF00019;PF00052;PF00053;PF00057;PF00063;PF00076;PF00093;PF00122;PF00130;PF00133;PF00168;PF00169;PF00307;PF00373;PF00400;PF00435;PF00452;PF00564;PF00583;PF00622;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00884;PF00989;PF01030;PF01391;PF01392;PF01403;PF02008;PF02145;PF02185;PF02377;PF03165;PF05033;PF06297;PF07525;PF07645;PF07653;PF07679;PF07686;PF08736;PF09379;PF09380;PF12548;PF12796
Group	GO:0000003	reproduction	1	5.84	7.27e-08	1.00e-06	62|275|412|3527	PF00019;PF00045;PF00053;PF00063;PF00076;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00258;PF00270;PF00271;PF00307;PF00350;PF00385;PF00400;PF00413;PF00435;PF00452;PF00564;PF00618;PF00622;PF00651;PF00667;PF00688;PF00702;PF00754;PF00757;PF00780;PF00989;PF01030;PF01335;PF01392;PF01465;PF01471;PF01553;PF01562;PF01751;PF01753;PF02177;PF02181;PF02518;PF02865;PF03165;PF04408;PF05033;PF07525;PF07653;PF07679;PF07686;PF09335;PF12478;PF12796;PF12924;PF13589;PF13855;PF13920;PF14259
Group	GO:0040011	locomotion	1	5.80	1.22e-07	1.57e-06	54|275|342|3527	PF00019;PF00024;PF00045;PF00052;PF00053;PF00057;PF00063;PF00130;PF00169;PF00226;PF00241;PF00307;PF00373;PF00413;PF00435;PF00515;PF00611;PF00618;PF00651;PF00688;PF00754;PF00757;PF00778;PF00780;PF01030;PF01391;PF01392;PF01403;PF01437;PF01471;PF01562;PF01833;PF02145;PF02148;PF02177;PF02185;PF02214;PF02518;PF03165;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07686;PF08736;PF10409;PF10524;PF11971;PF12924;PF13855;PF14429
Group	GO:0002376	immune system process	1	5.35	8.75e-07	9.47e-06	51|275|334|3527	PF00019;PF00020;PF00057;PF00059;PF00063;PF00085;PF00130;PF00153;PF00168;PF00169;PF00179;PF00240;PF00254;PF00270;PF00271;PF00350;PF00452;PF00605;PF00651;PF00688;PF00780;PF00969;PF01033;PF01335;PF01391;PF01392;PF01433;PF01476;PF01562;PF01909;PF02138;PF02218;PF02263;PF02865;PF02891;PF04810;PF05790;PF07534;PF07645;PF07653;PF07679;PF07686;PF08246;PF10409;PF11971;PF12697;PF12796;PF13637;PF13639;PF13855;PF14324
Group	GO:0051716	cellular response to stimulus	1	4.76	3.18e-06	2.86e-05	99|275|853|3527	PF00019;PF00020;PF00027;PF00040;PF00057;PF00059;PF00063;PF00076;PF00082;PF00085;PF00093;PF00122;PF00130;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00373;PF00400;PF00435;PF00452;PF00501;PF00564;PF00583;PF00605;PF00611;PF00618;PF00622;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00754;PF00757;PF00778;PF00780;PF00884;PF00899;PF00969;PF00989;PF01030;PF01302;PF01336;PF01370;PF01391;PF01392;PF01403;PF01412;PF01437;PF01562;PF01833;PF01909;PF02140;PF02145;PF02177;PF02185;PF02263;PF02377;PF02518;PF02759;PF02824;PF02865;PF02891;PF03165;PF05773;PF05790;PF06733;PF07525;PF07645;PF07653;PF07679;PF07686;PF07707;PF08246;PF08506;PF10391;PF10409;PF11717;PF11971;PF12548;PF12763;PF12796;PF12842;PF12924;PF13086;PF13405;PF13589;PF13639;PF13716;PF13848;PF13855;PF14324
Group	GO:0009056	catabolic process	1	4.81	4.37e-06	3.77e-05	70|275|543|3527	PF00019;PF00063;PF00082;PF00085;PF00097;PF00122;PF00149;PF00153;PF00168;PF00179;PF00205;PF00226;PF00240;PF00258;PF00270;PF00271;PF00289;PF00349;PF00350;PF00400;PF00452;PF00456;PF00501;PF00515;PF00557;PF00564;PF00583;PF00622;PF00642;PF00667;PF00688;PF00689;PF00690;PF00702;PF00789;PF00899;PF00970;PF01370;PF01391;PF01433;PF01477;PF01485;PF01546;PF01597;PF01841;PF01909;PF02148;PF02214;PF02263;PF02518;PF02770;PF02771;PF03256;PF04389;PF05020;PF05021;PF07707;PF08210;PF08246;PF09409;PF10409;PF12697;PF12842;PF12895;PF13086;PF13519;PF13589;PF13639;PF13920;PF14259
Group	GO:0009889	regulation of biosynthetic process	1	4.49	1.38e-05	1.03e-04	78|275|646|3527	PF00019;PF00020;PF00059;PF00076;PF00097;PF00130;PF00168;PF00169;PF00179;PF00270;PF00271;PF00307;PF00349;PF00385;PF00400;PF00435;PF00515;PF00564;PF00605;PF00642;PF00651;PF00688;PF00757;PF00899;PF00989;PF01030;PF01088;PF01302;PF01336;PF01352;PF01391;PF01392;PF01426;PF01585;PF01753;PF01833;PF02008;PF02177;PF02198;PF02201;PF02518;PF02865;PF02891;PF03165;PF03920;PF04762;PF04818;PF05033;PF05773;PF07528;PF07531;PF07645;PF07679;PF07686;PF07973;PF08210;PF08313;PF08662;PF08711;PF08788;PF09816;PF10524;PF11717;PF11934;PF12047;PF12796;PF12895;PF12924;PF13086;PF13405;PF13716;PF13831;PF13832;PF13854;PF13855;PF13920;PF14259;PF14324
Group	GO:0044260	cellular macromolecule metabolic process	1	4.21	2.00e-05	1.39e-04	144|275|1425|3527	PF00019;PF00027;PF00057;PF00063;PF00076;PF00082;PF00085;PF00094;PF00097;PF00122;PF00130;PF00133;PF00149;PF00168;PF00169;PF00179;PF00226;PF00240;PF00254;PF00258;PF00270;PF00271;PF00373;PF00385;PF00400;PF00415;PF00432;PF00452;PF00515;PF00534;PF00535;PF00557;PF00564;PF00583;PF00605;PF00611;PF00622;PF00642;PF00651;PF00667;PF00675;PF00688;PF00702;PF00754;PF00757;PF00780;PF00789;PF00884;PF00899;PF00989;PF01030;PF01088;PF01189;PF01302;PF01336;PF01370;PF01426;PF01480;PF01485;PF01562;PF01585;PF01663;PF01751;PF01753;PF01805;PF01841;PF01909;PF02008;PF02148;PF02177;PF02185;PF02198;PF02201;PF02214;PF02225;PF02434;PF02518;PF02824;PF02865;PF02891;PF03133;PF03165;PF03256;PF04137;PF04389;PF04408;PF04561;PF04563;PF04762;PF04810;PF04818;PF04868;PF05020;PF05021;PF05033;PF05193;PF05773;PF06464;PF06733;PF07034;PF07528;PF07531;PF07645;PF07653;PF07679;PF07707;PF07973;PF08075;PF08210;PF08662;PF08711;PF08736;PF08926;PF09379;PF09380;PF09409;PF10391;PF10409;PF10524;PF11717;PF12047;PF12548;PF12697;PF12796;PF12842;PF12894;PF12895;PF12906;PF12924;PF13086;PF13344;PF13519;PF13589;PF13637;PF13639;PF13691;PF13733;PF13831;PF13832;PF13848;PF13855;PF13920;PF14259;PF14324
Group	GO:0042060	wound healing	2	9.57	2.16e-13	1.39e-11	30|275|85|3527	PF00024;PF00027;PF00063;PF00093;PF00094;PF00122;PF00130;PF00168;PF00169;PF00307;PF00373;PF00435;PF00618;PF00622;PF00689;PF00690;PF00702;PF00754;PF00757;PF01030;PF01826;PF01841;PF04389;PF06920;PF07653;PF07679;PF07686;PF08742;PF13716;PF14429
Group	GO:0001932	regulation of protein phosphorylation	2	8.47	2.26e-12	1.08e-10	42|275|169|3527	PF00019;PF00020;PF00027;PF00057;PF00097;PF00169;PF00226;PF00240;PF00373;PF00400;PF00415;PF00452;PF00564;PF00688;PF00757;PF00778;PF00780;PF01030;PF01302;PF01391;PF01392;PF01403;PF01437;PF01585;PF02145;PF02177;PF02218;PF02377;PF04868;PF07525;PF07645;PF07653;PF07679;PF09379;PF09380;PF11934;PF12796;PF12924;PF13405;PF13716;PF13855;PF13920
Group	GO:0007444	imaginal disc development	2	8.84	9.01e-12	3.85e-10	27|275|79|3527	PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00651;PF01426;PF01471;PF01476;PF01833;PF02891;PF03165;PF07534;PF07645;PF07653;PF07679;PF07686;PF09379;PF12796;PF13637;PF13855;PF13920;PF14259;PF14324
Group	GO:0006461	protein complex assembly	2	7.98	2.15e-11	8.32e-10	42|275|180|3527	PF00019;PF00063;PF00093;PF00094;PF00130;PF00168;PF00169;PF00179;PF00289;PF00350;PF00400;PF00452;PF00515;PF00564;PF00611;PF00622;PF00688;PF00757;PF00778;PF00969;PF01030;PF01302;PF01391;PF01826;PF02141;PF02148;PF02181;PF02214;PF02263;PF02771;PF03165;PF03455;PF04695;PF06309;PF06367;PF06371;PF07645;PF07651;PF07679;PF08742;PF12763;PF13405
Group	GO:0009968	negative regulation of signal transduction	2	7.91	4.41e-11	1.63e-09	39|275|162|3527	PF00019;PF00057;PF00093;PF00130;PF00168;PF00169;PF00373;PF00400;PF00651;PF00683;PF00688;PF00778;PF00884;PF01302;PF01391;PF01392;PF01585;PF01833;PF02145;PF02214;PF02865;PF02891;PF03165;PF03226;PF03920;PF07525;PF07645;PF07679;PF09289;PF09379;PF09380;PF10409;PF12548;PF12763;PF12796;PF13405;PF13639;PF13855;PF14324
Group	GO:0007552	metamorphosis	2	8.43	7.45e-11	2.42e-09	25|275|74|3527	PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00651;PF01426;PF01471;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07686;PF08736;PF09379;PF10409;PF12796;PF13855;PF13920;PF14259
Group	GO:0006508	proteolysis	2	7.74	7.24e-11	2.42e-09	41|275|179|3527	PF00040;PF00045;PF00057;PF00063;PF00076;PF00082;PF00085;PF00097;PF00168;PF00179;PF00226;PF00240;PF00400;PF00413;PF00452;PF00515;PF00622;PF00675;PF00789;PF01433;PF01471;PF01485;PF01546;PF01562;PF02148;PF02214;PF02225;PF03256;PF04389;PF05020;PF05021;PF05193;PF07687;PF07707;PF08246;PF12895;PF13405;PF13519;PF13589;PF13639;PF13920
Group	GO:2000145	regulation of cell motility	2	8.13	7.86e-11	2.45e-09	30|275|104|3527	PF00019;PF00045;PF00086;PF00093;PF00130;PF00168;PF00373;PF00413;PF00688;PF00757;PF00884;PF01030;PF01044;PF01391;PF01392;PF01403;PF01437;PF01471;PF01562;PF01833;PF02185;PF07546;PF07645;PF07653;PF07679;PF08246;PF10409;PF12548;PF13716;PF13855
Group	GO:0002165	instar larval or pupal development	2	8.25	1.13e-10	3.39e-09	26|275|81|3527	PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00651;PF01426;PF01471;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07686;PF08736;PF09379;PF09380;PF10409;PF12796;PF13855;PF13920;PF14259
Group	GO:0009886	post-embryonic morphogenesis	2	8.11	1.56e-10	4.53e-09	27|275|88|3527	PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00452;PF00651;PF01426;PF01471;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07686;PF08736;PF09379;PF09380;PF10409;PF12796;PF13855;PF13920;PF14259
Group	GO:0031329	regulation of cellular catabolic process	2	7.79	2.51e-10	6.79e-09	31|275|115|3527	PF00027;PF00063;PF00076;PF00130;PF00168;PF00169;PF00226;PF00240;PF00271;PF00307;PF00373;PF00400;PF00515;PF00611;PF00618;PF00642;PF00778;PF00780;PF00789;PF01403;PF01412;PF01437;PF02145;PF02148;PF06920;PF07653;PF11971;PF12697;PF13716;PF13855;PF14429
Group	GO:0050817	coagulation	2	8.00	7.46e-10	1.84e-08	22|275|64|3527	PF00024;PF00027;PF00059;PF00093;PF00094;PF00122;PF00130;PF00169;PF00307;PF00373;PF00618;PF00689;PF00690;PF00702;PF00754;PF01826;PF01841;PF06920;PF07679;PF07686;PF08742;PF14429
Group	GO:0007292	female gamete generation	2	7.82	8.95e-10	2.10e-08	24|275|76|3527	PF00063;PF00076;PF00130;PF00168;PF00258;PF00270;PF00271;PF00307;PF00350;PF00385;PF00435;PF00564;PF00618;PF00622;PF00651;PF00667;PF01562;PF03165;PF07525;PF07653;PF07679;PF07686;PF13920;PF14259
Group	GO:0060541	respiratory system development	2	7.75	9.06e-10	2.10e-08	25|275|82|3527	PF00019;PF00045;PF00057;PF00059;PF00130;PF00240;PF00307;PF00413;PF00435;PF00564;PF00688;PF01391;PF01471;PF02181;PF03165;PF06367;PF06371;PF07645;PF07653;PF07679;PF08246;PF10409;PF10524;PF13855;PF13903
Group	GO:0030198	extracellular matrix organization	2	7.63	3.53e-09	7.52e-08	21|275|63|3527	PF00019;PF00045;PF00052;PF00053;PF00057;PF00063;PF00086;PF00093;PF00413;PF00688;PF01391;PF01392;PF01471;PF01562;PF02177;PF04810;PF07679;PF12924;PF13716;PF13733;PF13855
Group	GO:0007346	regulation of mitotic cell cycle	2	7.26	3.78e-09	7.67e-08	27|275|100|3527	PF00019;PF00076;PF00130;PF00168;PF00270;PF00271;PF00452;PF00515;PF00688;PF01426;PF02148;PF02177;PF02865;PF02891;PF06733;PF07653;PF07679;PF07686;PF09058;PF10608;PF11934;PF12796;PF12895;PF12924;PF13086;PF13639;PF14324
Group	GO:0050878	regulation of body fluid levels	2	7.34	5.03e-09	9.51e-08	24|275|82|3527	PF00024;PF00027;PF00059;PF00093;PF00094;PF00122;PF00130;PF00169;PF00307;PF00373;PF00618;PF00689;PF00690;PF00702;PF00754;PF01553;PF01826;PF01841;PF02865;PF06920;PF07679;PF07686;PF08742;PF14429
Group	GO:0018193	peptidyl-amino acid modification	2	6.80	8.42e-09	1.52e-07	34|275|153|3527	PF00085;PF00130;PF00168;PF00169;PF00240;PF00254;PF00258;PF00373;PF00400;PF00535;PF00557;PF00583;PF00611;PF00667;PF00754;PF00757;PF00899;PF01030;PF01302;PF01753;PF02518;PF02865;PF03133;PF04389;PF04810;PF05033;PF07645;PF07679;PF11717;PF12796;PF13733;PF13831;PF13832;PF13855
Group	GO:0016477	cell migration	2	6.64	1.07e-08	1.85e-07	38|275|185|3527	PF00019;PF00045;PF00052;PF00053;PF00057;PF00063;PF00130;PF00307;PF00413;PF00435;PF00515;PF00611;PF00618;PF00688;PF00754;PF00757;PF00778;PF01030;PF01403;PF01437;PF01471;PF01562;PF01833;PF02148;PF02185;PF02214;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07686;PF10409;PF11971;PF13855;PF14429
Group	GO:0051056	regulation of small GTPase mediated signal transduction	2	7.08	2.24e-08	3.71e-07	21|275|69|3527	PF00063;PF00130;PF00168;PF00169;PF00611;PF00618;PF00651;PF00780;PF01403;PF01412;PF01437;PF01833;PF02145;PF02214;PF06920;PF07653;PF07679;PF12796;PF13716;PF13855;PF14429
Group	GO:0035239	tube morphogenesis	2	6.66	3.56e-08	5.66e-07	27|275|110|3527	PF00019;PF00045;PF00130;PF00168;PF00307;PF00400;PF00413;PF00435;PF00564;PF00651;PF00688;PF00754;PF00989;PF01391;PF01392;PF01403;PF01437;PF01471;PF02145;PF03165;PF05033;PF07653;PF07679;PF07686;PF07707;PF08246;PF13855
Group	GO:0048569	post-embryonic organ development	2	6.70	4.83e-08	7.41e-07	24|275|91|3527	PF00045;PF00063;PF00076;PF00130;PF00307;PF00373;PF00413;PF00435;PF00452;PF00651;PF01426;PF01471;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07686;PF09379;PF12796;PF13855;PF13920;PF14259
Group	GO:0008360	regulation of cell shape	2	6.86	7.11e-08	9.95e-07	19|275|61|3527	PF00024;PF00063;PF00130;PF00169;PF00373;PF00611;PF00618;PF00780;PF01403;PF01437;PF02181;PF06367;PF06371;PF07679;PF07686;PF08736;PF09379;PF09380;PF10409
Group	GO:0034330	cell junction organization	2	6.80	7.08e-08	9.95e-07	20|275|67|3527	PF00019;PF00052;PF00053;PF00130;PF00168;PF00169;PF00307;PF00373;PF00435;PF00564;PF00688;PF01044;PF01391;PF07645;PF07653;PF07679;PF07686;PF09379;PF09380;PF13903
Group	GO:0043549	regulation of kinase activity	2	6.37	6.87e-08	9.95e-07	30|275|135|3527	PF00019;PF00027;PF00097;PF00169;PF00240;PF00400;PF00415;PF00564;PF00688;PF00778;PF00780;PF01391;PF01392;PF01585;PF02145;PF02177;PF04868;PF07525;PF07645;PF07653;PF07679;PF09379;PF09380;PF11934;PF12796;PF12924;PF13405;PF13716;PF13855;PF13920
Group	GO:0010740	positive regulation of intracellular protein kinase cascade	2	6.67	8.76e-08	1.19e-06	21|275|74|3527	PF00019;PF00020;PF00122;PF00130;PF00179;PF00240;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF01030;PF01391;PF01485;PF02218;PF07653;PF07679;PF12763;PF13920
Group	GO:0035107	appendage morphogenesis	2	6.50	9.54e-08	1.27e-06	24|275|94|3527	PF00057;PF00063;PF00076;PF00130;PF00168;PF00307;PF00373;PF00435;PF00452;PF00651;PF00884;PF01426;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF09379;PF12548;PF12796;PF13855;PF13920;PF14259
Group	GO:0035556	intracellular signal transduction	2	6.11	1.03e-07	1.35e-06	36|275|184|3527	PF00027;PF00063;PF00122;PF00130;PF00149;PF00168;PF00169;PF00240;PF00270;PF00400;PF00435;PF00452;PF00564;PF00611;PF00618;PF00651;PF00689;PF00690;PF00702;PF00780;PF01302;PF01412;PF02145;PF02185;PF02759;PF02865;PF07525;PF07645;PF07653;PF07679;PF08246;PF10409;PF11971;PF12763;PF13716;PF13855
Group	GO:0044057	regulation of system process	2	6.22	1.72e-07	2.15e-06	27|275|118|3527	PF00019;PF00027;PF00063;PF00122;PF00130;PF00168;PF00169;PF00254;PF00258;PF00435;PF00618;PF00667;PF00688;PF00689;PF00690;PF00702;PF01391;PF01699;PF01833;PF02214;PF03226;PF07653;PF07679;PF07686;PF10608;PF12796;PF13855
Group	GO:0030155	regulation of cell adhesion	2	6.36	2.06e-07	2.54e-06	22|275|84|3527	PF00019;PF00063;PF00086;PF00093;PF00130;PF00149;PF00168;PF00169;PF00373;PF00651;PF00688;PF00754;PF01391;PF01392;PF01562;PF02865;PF07645;PF07653;PF07679;PF10409;PF11971;PF13716
Group	GO:0048737	imaginal disc-derived appendage development	2	6.56	2.27e-07	2.75e-06	18|275|59|3527	PF00063;PF00076;PF00130;PF00307;PF00373;PF00435;PF00651;PF01426;PF01476;PF01833;PF03165;PF07534;PF07645;PF09379;PF12796;PF13855;PF13920;PF14259
Group	GO:0030163	protein catabolic process	2	6.13	2.63e-07	3.14e-06	26|275|113|3527	PF00082;PF00085;PF00097;PF00168;PF00179;PF00226;PF00240;PF00400;PF00452;PF00515;PF00622;PF00789;PF01485;PF01841;PF02148;PF02214;PF03256;PF05020;PF05021;PF07707;PF09409;PF12895;PF13519;PF13589;PF13639;PF13920
Group	GO:0051241	negative regulation of multicellular organismal process	2	6.34	3.75e-07	4.40e-06	19|275|67|3527	PF00019;PF00086;PF00122;PF00169;PF00240;PF00651;PF00688;PF00689;PF00690;PF00702;PF00969;PF01391;PF01699;PF02865;PF06741;PF07525;PF07645;PF10409;PF12796
Group	GO:0032880	regulation of protein localization	2	6.23	3.79e-07	4.40e-06	21|275|80|3527	PF00019;PF00020;PF00059;PF00085;PF00097;PF00307;PF00564;PF00622;PF00688;PF00757;PF00778;PF00969;PF01030;PF01302;PF01391;PF01392;PF07686;PF12796;PF13405;PF13716;PF13855
Group	GO:0060341	regulation of cellular localization	2	5.87	4.35e-07	4.97e-06	30|275|146|3527	PF00019;PF00020;PF00027;PF00059;PF00063;PF00076;PF00085;PF00097;PF00168;PF00169;PF00307;PF00349;PF00618;PF00622;PF00688;PF00757;PF00778;PF00969;PF01030;PF01302;PF01391;PF01392;PF01833;PF02214;PF04810;PF07686;PF12796;PF13405;PF13716;PF13855
Group	GO:0045786	negative regulation of cell cycle	2	6.35	5.40e-07	6.09e-06	17|275|56|3527	PF00019;PF00270;PF00271;PF00350;PF00605;PF00688;PF01477;PF02148;PF06733;PF07645;PF07653;PF07679;PF09058;PF10409;PF10608;PF11934;PF13086
Group	GO:0051130	positive regulation of cellular component organization	2	5.90	7.36e-07	8.08e-06	24|275|104|3527	PF00019;PF00059;PF00168;PF00241;PF00400;PF00452;PF00515;PF00611;PF00688;PF01302;PF01391;PF01403;PF01437;PF02181;PF02185;PF03165;PF06367;PF06371;PF07653;PF07679;PF07686;PF12796;PF13637;PF13855
Group	GO:0051235	maintenance of location	2	6.51	9.21e-07	9.84e-06	13|275|35|3527	PF00122;PF00241;PF00307;PF00400;PF00435;PF00683;PF00689;PF00690;PF00702;PF01044;PF07645;PF11971;PF12796
Group	GO:0006468	protein phosphorylation	2	5.67	1.04e-06	1.10e-05	28|275|136|3527	PF00019;PF00027;PF00063;PF00130;PF00168;PF00169;PF00240;PF00373;PF00564;PF00611;PF00688;PF00754;PF00757;PF00780;PF00989;PF01030;PF02177;PF02185;PF02518;PF02865;PF03165;PF04868;PF07645;PF07653;PF07679;PF08926;PF12924;PF13855
Group	GO:0001654	eye development	2	5.72	1.19e-06	1.24e-05	25|275|114|3527	PF00019;PF00053;PF00063;PF00130;PF00168;PF00373;PF00400;PF00415;PF00452;PF00564;PF00618;PF00651;PF00688;PF01392;PF01602;PF02865;PF02891;PF07679;PF08736;PF09379;PF09380;PF10409;PF13716;PF13920;PF14324
Group	GO:0008285	negative regulation of cell proliferation	2	5.75	1.35e-06	1.39e-05	23|275|100|3527	PF00019;PF00350;PF00373;PF00688;PF00754;PF00884;PF00969;PF01391;PF01753;PF02145;PF02865;PF03165;PF06297;PF07679;PF07686;PF09379;PF09380;PF10409;PF10524;PF10608;PF12548;PF13716;PF13733
Group	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2	5.82	1.40e-06	1.42e-05	21|275|86|3527	PF00019;PF00130;PF00168;PF00169;PF00307;PF00618;PF00688;PF00754;PF00757;PF00884;PF01030;PF02145;PF02865;PF07525;PF07645;PF07653;PF07679;PF07686;PF10409;PF12548;PF13855
Group	GO:0034762	regulation of transmembrane transport	2	5.80	1.69e-06	1.66e-05	20|275|80|3527	PF00019;PF00085;PF00168;PF00254;PF00307;PF00622;PF00688;PF00757;PF00778;PF01030;PF01302;PF01391;PF01392;PF07653;PF12796;PF13405;PF13637;PF13716;PF13855;PF13903
Group	GO:0007411	axon guidance	2	5.80	1.69e-06	1.66e-05	20|275|80|3527	PF00052;PF00307;PF00435;PF00651;PF00754;PF00778;PF00780;PF01391;PF01403;PF01437;PF01833;PF02148;PF02177;PF03165;PF07645;PF07679;PF08736;PF10524;PF12924;PF13855
Group	GO:0032446	protein modification by small protein conjugation	2	5.62	1.68e-06	1.66e-05	25|275|116|3527	PF00097;PF00168;PF00179;PF00240;PF00415;PF00622;PF00651;PF00899;PF01485;PF02148;PF02201;PF02214;PF02225;PF02891;PF03256;PF05773;PF07707;PF12796;PF12894;PF12895;PF12906;PF13637;PF13639;PF13920;PF14324
Group	GO:0010564	regulation of cell cycle process	2	5.57	1.80e-06	1.72e-05	26|275|124|3527	PF00019;PF00076;PF00130;PF00149;PF00168;PF00240;PF00270;PF00271;PF00400;PF00452;PF00515;PF00688;PF01336;PF01426;PF02148;PF02185;PF02891;PF06733;PF07679;PF07686;PF11934;PF12796;PF12895;PF13086;PF13639;PF14324
Group	GO:0048610	cellular process involved in reproduction	2	5.37	1.80e-06	1.72e-05	35|275|197|3527	PF00019;PF00063;PF00076;PF00130;PF00149;PF00168;PF00179;PF00240;PF00270;PF00271;PF00307;PF00350;PF00385;PF00435;PF00452;PF00564;PF00622;PF00651;PF00688;PF01562;PF01751;PF01753;PF02518;PF02865;PF03165;PF04408;PF05033;PF07525;PF07653;PF07679;PF07686;PF12796;PF13589;PF13920;PF14259
Group	GO:0006909	phagocytosis	2	6.00	2.29e-06	2.14e-05	15|275|49|3527	PF00053;PF00057;PF00059;PF00130;PF00400;PF01033;PF01217;PF01391;PF01426;PF01562;PF07546;PF07645;PF07679;PF07686;PF11971
Group	GO:0016337	cell-cell adhesion	2	6.00	2.29e-06	2.14e-05	15|275|49|3527	PF00059;PF00122;PF00169;PF00373;PF00688;PF00689;PF00690;PF00702;PF00884;PF07679;PF07686;PF09058;PF10608;PF12548;PF13855
Group	GO:0001763	morphogenesis of a branching structure	2	5.80	2.34e-06	2.16e-05	18|275|68|3527	PF00019;PF00045;PF00130;PF00307;PF00413;PF00435;PF00564;PF00688;PF00754;PF01403;PF01437;PF01471;PF01833;PF07645;PF07653;PF07679;PF08246;PF13855
Group	GO:0007015	actin filament organization	2	5.73	3.38e-06	2.98e-05	17|275|63|3527	PF00063;PF00241;PF00307;PF00373;PF00400;PF00611;PF02181;PF02214;PF06367;PF06371;PF07653;PF09058;PF09379;PF09380;PF10409;PF10608;PF12796
Group	GO:0010769	regulation of cell morphogenesis involved in differentiation	2	5.73	3.38e-06	2.98e-05	17|275|63|3527	PF00019;PF00086;PF00307;PF00435;PF00515;PF00688;PF00780;PF01403;PF01437;PF01562;PF01833;PF02181;PF03165;PF06367;PF06371;PF07679;PF13855
Group	GO:0021700	developmental maturation	2	5.65	3.69e-06	3.22e-05	18|275|70|3527	PF00019;PF00076;PF00130;PF00169;PF00435;PF00564;PF00622;PF00651;PF00688;PF01833;PF02177;PF07525;PF07679;PF10608;PF12796;PF12924;PF13855;PF14259
Group	GO:0051248	negative regulation of protein metabolic process	2	5.32	4.47e-06	3.82e-05	25|275|122|3527	PF00019;PF00076;PF00226;PF00240;PF00307;PF00373;PF00400;PF00452;PF00688;PF00789;PF01335;PF01391;PF01585;PF02145;PF02148;PF05773;PF07525;PF09379;PF09380;PF11934;PF12796;PF13405;PF13716;PF13920;PF14259
Group	GO:0001558	regulation of cell growth	2	5.57	4.60e-06	3.86e-05	18|275|71|3527	PF00019;PF00086;PF00179;PF00226;PF00307;PF00435;PF00688;PF00754;PF00757;PF01030;PF01088;PF01403;PF01437;PF01562;PF07679;PF10409;PF12796;PF13855
Group	GO:0044092	negative regulation of molecular function	2	5.24	4.61e-06	3.86e-05	28|275|146|3527	PF00076;PF00086;PF00168;PF00169;PF00254;PF00258;PF00307;PF00373;PF00400;PF00452;PF00667;PF00688;PF01302;PF01391;PF01585;PF02145;PF02148;PF07525;PF07653;PF09324;PF09379;PF09380;PF10608;PF11934;PF12796;PF13405;PF13716;PF13920
Group	GO:0009798	axis specification	2	5.70	5.25e-06	4.30e-05	15|275|52|3527	PF00057;PF00063;PF00076;PF00130;PF00168;PF00400;PF00564;PF00622;PF00651;PF00778;PF03165;PF05033;PF06297;PF07525;PF14259
Group	GO:1900542	regulation of purine nucleotide metabolic process	2	5.41	5.69e-06	4.62e-05	20|275|86|3527	PF00027;PF00063;PF00130;PF00168;PF00169;PF00226;PF00307;PF00611;PF00618;PF00780;PF01403;PF01412;PF01437;PF02145;PF06920;PF07653;PF11971;PF13716;PF13855;PF14429
Group	GO:0030097	hemopoiesis	2	5.26	6.55e-06	5.27e-05	23|275|109|3527	PF00019;PF00063;PF00130;PF00153;PF00169;PF00452;PF00605;PF00651;PF00688;PF00780;PF01392;PF02218;PF02865;PF02891;PF05790;PF07645;PF07679;PF07686;PF11971;PF12796;PF13637;PF13855;PF14324
Group	GO:0051051	negative regulation of transport	2	5.50	7.82e-06	6.22e-05	16|275|60|3527	PF00019;PF00130;PF00168;PF00258;PF00307;PF00400;PF00611;PF00622;PF00667;PF00688;PF01302;PF01391;PF01833;PF12796;PF13405;PF13716
Group	GO:0008544	epidermis development	2	5.36	8.66e-06	6.83e-05	18|275|74|3527	PF00019;PF00063;PF00093;PF00122;PF00373;PF00400;PF00622;PF00688;PF00689;PF00702;PF00757;PF01030;PF01391;PF01392;PF06733;PF07679;PF12796;PF13855
Group	GO:0007610	behavior	2	5.03	9.11e-06	7.11e-05	28|275|151|3527	PF00027;PF00057;PF00063;PF00076;PF00122;PF00130;PF00168;PF00307;PF00435;PF00564;PF00651;PF00689;PF00690;PF00702;PF00970;PF00989;PF01465;PF01562;PF01699;PF02177;PF02214;PF02865;PF07653;PF12796;PF12924;PF13639;PF13716;PF13855
Group	GO:0007600	sensory perception	2	5.22	9.28e-06	7.18e-05	21|275|96|3527	PF00024;PF00027;PF00053;PF00063;PF00122;PF00307;PF00350;PF00373;PF00415;PF00689;PF00690;PF00702;PF01391;PF01477;PF07653;PF07679;PF07686;PF09379;PF12796;PF13385;PF13637
Group	GO:0042176	regulation of protein catabolic process	2	5.63	9.66e-06	7.40e-05	13|275|42|3527	PF00240;PF00307;PF00373;PF00400;PF00515;PF00778;PF00789;PF01335;PF02148;PF02891;PF07525;PF13920;PF14324
Group	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	2	5.52	1.29e-05	9.69e-05	13|275|43|3527	PF00019;PF00086;PF00093;PF00094;PF00683;PF00688;PF00884;PF01392;PF03165;PF07645;PF09289;PF12548;PF12796
Group	GO:0051216	cartilage development	2	5.52	1.29e-05	9.69e-05	13|275|43|3527	PF00019;PF00052;PF00053;PF00057;PF00093;PF00688;PF00884;PF01391;PF03165;PF07645;PF07679;PF10524;PF12548
Group	GO:0007268	synaptic transmission	2	4.92	1.40e-05	1.03e-04	27|275|146|3527	PF00063;PF00122;PF00130;PF00168;PF00169;PF00435;PF00622;PF00651;PF00690;PF00928;PF01044;PF01217;PF01302;PF01392;PF01602;PF02177;PF02214;PF03165;PF07653;PF07679;PF07690;PF07707;PF10608;PF12763;PF12796;PF12924;PF13855
Group	GO:0032844	regulation of homeostatic process	2	5.20	1.59e-05	1.14e-04	17|275|70|3527	PF00019;PF00057;PF00168;PF00179;PF00254;PF00307;PF00452;PF00622;PF00688;PF00969;PF02198;PF02865;PF03226;PF12796;PF13405;PF13637;PF13716
Group	GO:0032270	positive regulation of cellular protein metabolic process	2	4.85	1.89e-05	1.33e-04	26|275|140|3527	PF00019;PF00057;PF00076;PF00179;PF00240;PF00373;PF00400;PF00515;PF00564;PF00688;PF00757;PF00778;PF00780;PF01030;PF01302;PF01391;PF02218;PF02891;PF04868;PF07645;PF07653;PF07679;PF12763;PF13405;PF13855;PF14324
Group	GO:0010975	regulation of neuron projection development	2	5.18	1.92e-05	1.34e-04	16|275|64|3527	PF00254;PF00307;PF00435;PF00611;PF00780;PF01403;PF01437;PF01562;PF01833;PF02181;PF06367;PF06371;PF07679;PF10409;PF12796;PF13855
Group	GO:0080135	regulation of cellular response to stress	2	5.01	2.16e-05	1.49e-04	19|275|86|3527	PF00020;PF00040;PF00059;PF00097;PF00149;PF00168;PF00169;PF00179;PF00270;PF00271;PF00452;PF00778;PF00780;PF01392;PF01753;PF06733;PF07653;PF13639;PF13855
Group	GO:0032535	regulation of cellular component size	2	5.10	2.37e-05	1.61e-04	16|275|65|3527	PF00130;PF00168;PF00169;PF00241;PF00307;PF00400;PF00435;PF01403;PF01437;PF01562;PF02145;PF02181;PF07653;PF07679;PF10409;PF13855
Group	GO:0051301	cell division	2	4.88	2.78e-05	1.88e-04	20|275|95|3527	PF00019;PF00063;PF00076;PF00130;PF00169;PF00241;PF00271;PF00307;PF00350;PF00435;PF00452;PF00564;PF00651;PF00688;PF00780;PF02181;PF03165;PF06367;PF06371;PF07707
Group	GO:0001817	regulation of cytokine production	2	4.84	3.92e-05	2.55e-04	18|275|82|3527	PF00019;PF00020;PF00059;PF00076;PF00130;PF00240;PF00271;PF00605;PF00622;PF00642;PF00651;PF00688;PF00969;PF01391;PF02865;PF07686;PF12796;PF13855
Group	GO:0044087	regulation of cellular component biogenesis	2	4.73	3.96e-05	2.55e-04	21|275|105|3527	PF00063;PF00086;PF00130;PF00168;PF00241;PF00307;PF00373;PF00400;PF00452;PF00611;PF00622;PF01302;PF01392;PF02181;PF02518;PF03165;PF06367;PF06371;PF07653;PF10409;PF12796
Group	GO:0045597	positive regulation of cell differentiation	2	4.72	4.48e-05	2.82e-04	20|275|98|3527	PF00019;PF00086;PF00093;PF00130;PF00168;PF00400;PF00564;PF00688;PF01391;PF01403;PF01437;PF02198;PF02865;PF03165;PF07525;PF07645;PF07679;PF12796;PF13405;PF13855
Group	GO:0051240	positive regulation of multicellular organismal process	2	4.72	4.48e-05	2.82e-04	20|275|98|3527	PF00019;PF00027;PF00122;PF00130;PF00168;PF00169;PF00271;PF00605;PF00688;PF00689;PF00690;PF00702;PF01391;PF01699;PF02865;PF07645;PF07679;PF12796;PF13716;PF13855
Group	GO:0071310	cellular response to organic substance	2	4.39	5.02e-05	3.14e-04	36|275|237|3527	PF00019;PF00020;PF00076;PF00093;PF00130;PF00168;PF00169;PF00179;PF00226;PF00240;PF00270;PF00271;PF00307;PF00400;PF00452;PF00583;PF00605;PF00622;PF00688;PF00754;PF00757;PF00969;PF01030;PF01391;PF01909;PF02263;PF02518;PF02865;PF03165;PF07525;PF07653;PF07679;PF07686;PF10409;PF13639;PF13855
Group	GO:0048638	regulation of developmental growth	2	4.81	5.24e-05	3.25e-04	16|275|69|3527	PF00019;PF00063;PF00179;PF00307;PF00435;PF00611;PF00622;PF00688;PF01392;PF01403;PF01437;PF01562;PF03165;PF07679;PF13405;PF13855
Group	GO:0007009	plasma membrane organization	2	5.12	5.46e-05	3.36e-04	11|275|36|3527	PF00063;PF00168;PF00169;PF00307;PF00435;PF00611;PF00622;PF01391;PF12796;PF13405;PF13637
Group	GO:0007369	gastrulation	2	4.84	6.43e-05	3.93e-04	14|275|56|3527	PF00019;PF00076;PF00130;PF00168;PF00307;PF00373;PF00435;PF00583;PF00688;PF00778;PF03165;PF06297;PF09379;PF09380
Group	GO:0010942	positive regulation of cell death	2	4.52	6.99e-05	4.23e-04	22|275|117|3527	PF00019;PF00020;PF00169;PF00240;PF00270;PF00271;PF00307;PF00452;PF00605;PF00688;PF01302;PF01335;PF01391;PF01392;PF01585;PF02865;PF06733;PF07653;PF07679;PF08246;PF10409;PF13716
Group	GO:0072657	protein localization to membrane	2	5.00	7.24e-05	4.32e-04	11|275|37|3527	PF00053;PF00169;PF00611;PF01391;PF01392;PF07653;PF07679;PF10608;PF12796;PF13405;PF13637
Group	GO:0043269	regulation of ion transport	2	4.60	7.67e-05	4.55e-04	18|275|86|3527	PF00122;PF00168;PF00169;PF00254;PF00258;PF00307;PF00435;PF00452;PF00622;PF00667;PF00689;PF00690;PF00702;PF07653;PF07690;PF12796;PF13405;PF13903
Group	GO:0030111	regulation of Wnt receptor signaling pathway	2	4.76	7.94e-05	4.64e-04	14|275|57|3527	PF00019;PF00057;PF00400;PF00688;PF00778;PF00884;PF01302;PF01391;PF01392;PF07679;PF12548;PF12796;PF13637;PF13639
Group	GO:0060627	regulation of vesicle-mediated transport	2	4.76	7.94e-05	4.64e-04	14|275|57|3527	PF00059;PF00168;PF00169;PF00400;PF00611;PF00618;PF01302;PF01391;PF01833;PF02145;PF07645;PF07651;PF07686;PF13920
Group	GO:0044265	cellular macromolecule catabolic process	2	4.32	8.06e-05	4.68e-04	30|275|187|3527	PF00082;PF00085;PF00097;PF00168;PF00179;PF00226;PF00240;PF00271;PF00400;PF00452;PF00515;PF00622;PF00642;PF00789;PF01485;PF01909;PF02148;PF02214;PF03256;PF05020;PF05021;PF07707;PF12842;PF12895;PF13086;PF13519;PF13589;PF13639;PF13920;PF14259
Group	GO:0001568	blood vessel development	2	4.46	9.43e-05	5.43e-04	20|275|103|3527	PF00019;PF00063;PF00093;PF00168;PF00169;PF00373;PF00618;PF00688;PF01392;PF01403;PF01433;PF01437;PF01833;PF02198;PF02434;PF07645;PF07679;PF07686;PF12796;PF13716
Group	GO:0008283	cell proliferation	2	4.33	1.00e-04	5.71e-04	25|275|145|3527	PF00019;PF00020;PF00027;PF00076;PF00086;PF00130;PF00254;PF00452;PF00501;PF00564;PF00688;PF01392;PF01433;PF02148;PF02198;PF02865;PF03165;PF07653;PF07679;PF07686;PF08506;PF09058;PF10409;PF10608;PF13639
Group	GO:0001822	kidney development	2	4.55	1.08e-04	6.07e-04	16|275|73|3527	PF00019;PF00240;PF00400;PF00452;PF00651;PF00688;PF00884;PF01391;PF02434;PF02865;PF07679;PF07707;PF08246;PF10162;PF12548;PF13716
Group	GO:0030705	cytoskeleton-dependent intracellular transport	2	4.75	1.10e-04	6.09e-04	12|275|45|3527	PF00063;PF00169;PF00307;PF00400;PF00435;PF00928;PF00989;PF01217;PF01602;PF02177;PF12924;PF13405
Group	GO:0043122	regulation of I-kappaB kinase/NF-kappaB cascade	2	4.75	1.10e-04	6.09e-04	12|275|45|3527	PF00122;PF00179;PF00240;PF00689;PF00690;PF00702;PF01391;PF01485;PF02865;PF12796;PF13405;PF13920
Group	GO:0048732	gland development	2	4.48	1.17e-04	6.44e-04	17|275|81|3527	PF00122;PF00702;PF00754;PF00757;PF00989;PF01030;PF01391;PF01403;PF01553;PF01562;PF02198;PF02865;PF07679;PF07686;PF08736;PF10409;PF13716
Group	GO:0006066	alcohol metabolic process	2	4.37	1.43e-04	7.64e-04	18|275|90|3527	PF00019;PF00027;PF00057;PF00109;PF00205;PF00432;PF00501;PF00535;PF00688;PF00698;PF01066;PF01663;PF02177;PF02801;PF03765;PF07645;PF08659;PF12924
Group	GO:0007018	microtubule-based movement	2	4.53	1.44e-04	7.66e-04	14|275|60|3527	PF00063;PF00169;PF00307;PF00400;PF00435;PF00928;PF00989;PF01217;PF01302;PF01602;PF02177;PF03133;PF12924;PF13405
Group	GO:0006955	immune response	2	4.21	1.52e-04	7.95e-04	24|275|140|3527	PF00057;PF00059;PF00085;PF00130;PF00240;PF00271;PF00350;PF00605;PF00651;PF00969;PF01033;PF01391;PF02263;PF02865;PF07645;PF07679;PF07686;PF08246;PF10409;PF11971;PF12697;PF12796;PF13639;PF13855
Group	GO:0031532	actin cytoskeleton reorganization	2	5.14	1.60e-04	8.26e-04	7|275|17|3527	PF00122;PF00130;PF00689;PF00690;PF00702;PF00780;PF07686
Group	GO:2000027	regulation of organ morphogenesis	2	4.45	1.75e-04	8.64e-04	14|275|61|3527	PF00019;PF00086;PF00400;PF00452;PF00688;PF00778;PF00884;PF01392;PF02377;PF03165;PF07679;PF10524;PF12548;PF12796
Group	GO:0045927	positive regulation of growth	2	4.45	1.75e-04	8.64e-04	14|275|61|3527	PF00063;PF00133;PF00168;PF00169;PF00270;PF00271;PF00757;PF00989;PF01030;PF02865;PF03165;PF12796;PF13405;PF13716
Group	GO:0050776	regulation of immune response	2	4.21	1.81e-04	8.88e-04	21|275|116|3527	PF00057;PF00059;PF00130;PF00168;PF00169;PF00179;PF00240;PF00611;PF00651;PF00754;PF00969;PF01391;PF01476;PF02865;PF07534;PF07645;PF07679;PF07686;PF08246;PF13639;PF13855
Group	GO:0043408	regulation of MAPK cascade	2	4.30	1.88e-04	9.21e-04	17|275|84|3527	PF00020;PF00097;PF00130;PF00168;PF00169;PF00373;PF00757;PF00778;PF00780;PF01030;PF01391;PF01392;PF07653;PF07679;PF09379;PF09380;PF13855
Group	GO:0023061	signal release	2	4.38	2.10e-04	1.02e-03	14|275|62|3527	PF00019;PF00027;PF00063;PF00130;PF00168;PF00169;PF00618;PF00683;PF00688;PF00928;PF01217;PF01602;PF07645;PF12763
Group	GO:0051050	positive regulation of transport	2	4.21	2.21e-04	1.06e-03	18|275|93|3527	PF00019;PF00040;PF00059;PF00076;PF00168;PF00169;PF00307;PF00349;PF00400;PF00452;PF00688;PF00969;PF01302;PF01391;PF07686;PF12796;PF13405;PF13855
Group	GO:0010608	posttranscriptional regulation of gene expression	2	4.12	2.32e-04	1.09e-03	21|275|118|3527	PF00019;PF00076;PF00240;PF00270;PF00271;PF00307;PF00642;PF00757;PF01030;PF02148;PF02177;PF02985;PF05773;PF07973;PF08246;PF08662;PF10409;PF12924;PF13086;PF13405;PF14259
Group	GO:0042981	regulation of apoptotic process	2	3.92	2.41e-04	1.13e-03	34|275|236|3527	PF00019;PF00020;PF00024;PF00082;PF00086;PF00130;PF00168;PF00169;PF00240;PF00270;PF00271;PF00307;PF00452;PF00564;PF00605;PF00688;PF00757;PF01030;PF01302;PF01335;PF01391;PF01392;PF01585;PF02865;PF06733;PF07653;PF07679;PF08246;PF10409;PF12763;PF13405;PF13716;PF13855;PF13920
Group	GO:0016569	covalent chromatin modification	2	4.08	2.62e-04	1.21e-03	21|275|119|3527	PF00076;PF00097;PF00130;PF00168;PF00179;PF00254;PF00385;PF00400;PF00515;PF00583;PF00622;PF01088;PF01426;PF01753;PF02008;PF02148;PF05033;PF11717;PF12796;PF13831;PF13832
Group	GO:0006913	nucleocytoplasmic transport	2	4.23	2.75e-04	1.24e-03	15|275|71|3527	PF00019;PF00076;PF00270;PF00271;PF00688;PF01412;PF02145;PF02865;PF02985;PF03810;PF07645;PF08389;PF08506;PF12796;PF13405
Group	GO:0046903	secretion	2	4.08	2.75e-04	1.24e-03	20|275|111|3527	PF00019;PF00027;PF00063;PF00122;PF00130;PF00168;PF00169;PF00618;PF00683;PF00688;PF00702;PF00928;PF01217;PF01553;PF01602;PF02865;PF07645;PF07651;PF07679;PF12763
Group	GO:0051345	positive regulation of hydrolase activity	2	4.11	2.93e-04	1.31e-03	18|275|95|3527	PF00019;PF00063;PF00130;PF00168;PF00169;PF00226;PF00452;PF00611;PF00688;PF01412;PF02145;PF02865;PF06920;PF07679;PF08246;PF13716;PF13920;PF14429
Group	GO:0006605	protein targeting	2	4.03	2.95e-04	1.31e-03	21|275|120|3527	PF00019;PF00168;PF00226;PF00307;PF00432;PF00435;PF00515;PF00675;PF00688;PF02145;PF02865;PF02985;PF03810;PF04695;PF05193;PF07645;PF08389;PF08506;PF12796;PF13405;PF13855
Group	GO:0050808	synapse organization	2	4.38	3.19e-04	1.39e-03	11|275|43|3527	PF00063;PF00130;PF00564;PF00690;PF01392;PF02177;PF07653;PF07679;PF10608;PF12796;PF12924
Group	GO:0060348	bone development	2	4.38	3.19e-04	1.39e-03	11|275|43|3527	PF00019;PF00052;PF00053;PF00057;PF00622;PF00688;PF00884;PF01391;PF07645;PF07679;PF12548
Group	GO:0071103	DNA conformation change	2	4.26	3.18e-04	1.39e-03	13|275|57|3527	PF00270;PF00271;PF00385;PF00400;PF00583;PF00622;PF01426;PF01751;PF02518;PF02891;PF06733;PF13086;PF14324
Group	GO:0050865	regulation of cell activation	2	4.12	3.36e-04	1.45e-03	16|275|80|3527	PF00019;PF00020;PF00059;PF00086;PF00130;PF00168;PF00605;PF00611;PF00651;PF00688;PF00969;PF02865;PF05790;PF07653;PF07686;PF13405
Group	GO:0060249	anatomical structure homeostasis	2	4.08	3.39e-04	1.46e-03	17|275|88|3527	PF00059;PF00082;PF00270;PF00271;PF00373;PF00435;PF00452;PF01336;PF01391;PF06733;PF07679;PF07686;PF08246;PF08736;PF09379;PF09380;PF12796
Group	GO:0031589	cell-substrate adhesion	2	4.39	3.69e-04	1.56e-03	10|275|37|3527	PF00086;PF00094;PF01391;PF01392;PF01826;PF06119;PF07645;PF07686;PF08742;PF13637
Group	GO:0000278	mitotic cell cycle	2	3.91	3.89e-04	1.62e-03	22|275|131|3527	PF00019;PF00130;PF00179;PF00270;PF00271;PF00400;PF00452;PF00688;PF00780;PF01336;PF01833;PF02148;PF02177;PF02891;PF04499;PF07679;PF07686;PF12765;PF12842;PF12895;PF12924;PF14324
Group	GO:0051052	regulation of DNA metabolic process	2	4.04	4.42e-04	1.82e-03	15|275|74|3527	PF00019;PF00149;PF00179;PF00270;PF00271;PF00515;PF00651;PF00688;PF01336;PF01391;PF01751;PF06733;PF07679;PF12895;PF13086
Group	GO:0051494	negative regulation of cytoskeleton organization	2	4.28	4.67e-04	1.90e-03	10|275|38|3527	PF00086;PF00241;PF00254;PF00307;PF00400;PF00435;PF00622;PF01302;PF07653;PF12796
Group	GO:0000279	M phase	2	3.83	4.84e-04	1.95e-03	22|275|133|3527	PF00130;PF00149;PF00179;PF00240;PF00270;PF00271;PF00307;PF00385;PF00400;PF00651;PF00780;PF01751;PF02148;PF02518;PF04408;PF07679;PF07686;PF07707;PF12765;PF12796;PF12895;PF13589
Group	GO:0010562	positive regulation of phosphorus metabolic process	2	3.91	4.97e-04	1.99e-03	18|275|99|3527	PF00019;PF00057;PF00240;PF00564;PF00688;PF00778;PF00780;PF01302;PF01391;PF01392;PF01403;PF02218;PF04868;PF07645;PF07653;PF07679;PF12763;PF13855
Group	GO:0032259	methylation	2	3.95	5.20e-04	2.02e-03	16|275|83|3527	PF00076;PF00271;PF00385;PF00400;PF00515;PF00622;PF01189;PF01426;PF01585;PF01753;PF02008;PF04408;PF05033;PF06464;PF12047;PF12796
Group	GO:0051640	organelle localization	2	3.86	5.64e-04	2.18e-03	18|275|100|3527	PF00063;PF00130;PF00168;PF00169;PF00307;PF00350;PF00400;PF00435;PF00515;PF00651;PF00780;PF01302;PF01403;PF02181;PF04810;PF07707;PF13405;PF13920
Group	GO:0002252	immune effector process	2	3.87	5.85e-04	2.24e-03	17|275|92|3527	PF00057;PF00059;PF00130;PF00270;PF00271;PF00605;PF00969;PF01391;PF01909;PF02138;PF07645;PF07679;PF07686;PF08246;PF10409;PF13639;PF13855
Group	GO:0012501	programmed cell death	2	3.74	6.05e-04	2.31e-03	23|275|144|3527	PF00027;PF00130;PF00240;PF00349;PF00452;PF00564;PF00651;PF00757;PF00989;PF01030;PF01335;PF02141;PF02177;PF02865;PF03455;PF07653;PF08246;PF10409;PF12924;PF13405;PF13716;PF13855;PF13920
Group	GO:0045596	negative regulation of cell differentiation	2	3.77	6.34e-04	2.40e-03	20|275|118|3527	PF00019;PF00086;PF00307;PF00515;PF00605;PF00642;PF00688;PF00778;PF00780;PF01391;PF01403;PF02177;PF02865;PF03165;PF07645;PF07679;PF12796;PF12924;PF13716;PF14259
Group	GO:0002684	positive regulation of immune system process	2	3.77	6.34e-04	2.40e-03	20|275|118|3527	PF00020;PF00057;PF00059;PF00086;PF00130;PF00168;PF00169;PF00179;PF00240;PF00611;PF00651;PF00969;PF01391;PF01476;PF02865;PF05790;PF07534;PF07645;PF07686;PF13855
Group	GO:0003002	regionalization	2	3.72	6.65e-04	2.50e-03	22|275|136|3527	PF00019;PF00057;PF00063;PF00076;PF00093;PF00130;PF00168;PF00385;PF00400;PF00622;PF00651;PF00688;PF00778;PF01392;PF02008;PF02377;PF03165;PF05033;PF06297;PF07525;PF07679;PF12796
Group	GO:0048285	organelle fission	2	3.91	6.78e-04	2.54e-03	14|275|69|3527	PF00085;PF00307;PF00350;PF00385;PF00400;PF00452;PF00515;PF00780;PF01751;PF02148;PF05033;PF12765;PF12895;PF13920
Group	GO:0051347	positive regulation of transferase activity	2	3.87	6.90e-04	2.57e-03	15|275|77|3527	PF00019;PF00057;PF00169;PF00240;PF00400;PF00564;PF00688;PF00778;PF00780;PF01391;PF04868;PF07645;PF07653;PF07679;PF13855
Group	GO:0006357	regulation of transcription from RNA polymerase II promoter	2	3.64	7.05e-04	2.62e-03	26|275|173|3527	PF00019;PF00020;PF00400;PF00435;PF00651;PF00688;PF00989;PF01833;PF02177;PF02201;PF02865;PF03165;PF03920;PF04762;PF04818;PF07645;PF07679;PF08711;PF08788;PF10524;PF11934;PF12796;PF12924;PF13716;PF13854;PF13920
Group	GO:0048705	skeletal system morphogenesis	2	4.02	7.29e-04	2.68e-03	11|275|47|3527	PF00019;PF00052;PF00053;PF00057;PF00688;PF00884;PF01391;PF03165;PF07645;PF07679;PF12548
Group	GO:0032101	regulation of response to external stimulus	2	3.77	7.58e-04	2.76e-03	17|275|94|3527	PF00019;PF00020;PF00027;PF00130;PF00168;PF00688;PF00754;PF01391;PF01403;PF01437;PF01562;PF01833;PF02865;PF07653;PF07679;PF13405;PF13855
Group	GO:0007283	spermatogenesis	2	3.81	7.96e-04	2.89e-03	15|275|78|3527	PF00063;PF00179;PF00226;PF00240;PF00270;PF00350;PF00452;PF00651;PF00780;PF01562;PF01753;PF04408;PF07679;PF12796;PF14259
Group	GO:0048511	rhythmic process	2	3.91	8.29e-04	2.97e-03	12|275|55|3527	PF00019;PF00027;PF00076;PF00452;PF00583;PF00688;PF00989;PF01392;PF02518;PF02865;PF07679;PF13716
Group	GO:0032970	regulation of actin filament-based process	2	3.91	8.29e-04	2.97e-03	12|275|55|3527	PF00086;PF00130;PF00168;PF00169;PF00241;PF00373;PF00400;PF00611;PF02181;PF07653;PF07686;PF12796
Group	GO:0050678	regulation of epithelial cell proliferation	2	3.91	8.29e-04	2.97e-03	12|275|55|3527	PF00019;PF00130;PF00168;PF00688;PF00757;PF00884;PF01030;PF02865;PF03165;PF07679;PF10524;PF12548
Group	GO:0030003	cellular cation homeostasis	2	3.68	8.56e-04	3.05e-03	19|275|112|3527	PF00122;PF00130;PF00168;PF00254;PF00400;PF00452;PF00622;PF00689;PF00690;PF00702;PF01496;PF01699;PF02177;PF02225;PF04389;PF07690;PF12710;PF12924;PF13405
Group	GO:0002697	regulation of immune effector process	2	3.83	8.89e-04	3.08e-03	13|275|63|3527	PF00020;PF00059;PF00097;PF00168;PF00169;PF00611;PF00651;PF00754;PF01217;PF01602;PF02865;PF07686;PF13855
Group	GO:0017038	protein import	2	3.83	8.89e-04	3.08e-03	13|275|63|3527	PF00019;PF00226;PF00400;PF00515;PF00675;PF00688;PF02145;PF02865;PF03810;PF04695;PF05193;PF07645;PF12796
Group	GO:0045893	positive regulation of transcription, DNA-dependent	2	3.59	8.98e-04	3.10e-03	23|275|148|3527	PF00019;PF00020;PF00400;PF00435;PF00605;PF00688;PF00757;PF00989;PF01030;PF01833;PF02177;PF02865;PF03165;PF07645;PF08210;PF08313;PF08788;PF09816;PF10524;PF12796;PF12924;PF13405;PF13716
Group	GO:0033365	protein localization to organelle	2	3.63	9.58e-04	3.29e-03	19|275|113|3527	PF00019;PF00168;PF00226;PF00240;PF00307;PF00350;PF00435;PF00515;PF00675;PF00688;PF02145;PF02865;PF03810;PF04695;PF05193;PF07645;PF08389;PF08506;PF12796
Group	GO:0006898	receptor-mediated endocytosis	2	4.12	9.65e-04	3.31e-03	8|275|28|3527	PF00040;PF00057;PF00059;PF00169;PF00350;PF00611;PF07645;PF07651
Group	GO:0016331	morphogenesis of embryonic epithelium	2	3.77	1.04e-03	3.53e-03	13|275|64|3527	PF00063;PF00130;PF00373;PF00564;PF01392;PF02145;PF02185;PF07653;PF07679;PF08736;PF09379;PF09380;PF12796
Group	GO:0016358	dendrite development	2	3.85	1.06e-03	3.55e-03	11|275|49|3527	PF00024;PF00053;PF00307;PF00435;PF00780;PF01044;PF02177;PF07653;PF07679;PF12796;PF12924
Group	GO:0008038	neuron recognition	2	4.06	1.34e-03	4.35e-03	7|275|23|3527	PF00307;PF00435;PF00651;PF01437;PF02177;PF07679;PF12924
Group	GO:0006304	DNA modification	2	3.80	1.34e-03	4.35e-03	10|275|43|3527	PF00270;PF00271;PF01426;PF02008;PF04408;PF05033;PF06464;PF08210;PF12047;PF12796
Group	GO:0009725	response to hormone stimulus	2	3.45	1.33e-03	4.35e-03	22|275|143|3527	PF00019;PF00045;PF00130;PF00169;PF00307;PF00413;PF00452;PF00515;PF00688;PF00757;PF01030;PF01391;PF01471;PF01554;PF02218;PF02518;PF02865;PF07525;PF07653;PF10409;PF13639;PF13855
Group	GO:0034621	cellular macromolecular complex subunit organization	2	3.41	1.35e-03	4.35e-03	25|275|171|3527	PF00019;PF00063;PF00076;PF00130;PF00168;PF00169;PF00179;PF00241;PF00270;PF00271;PF00307;PF00400;PF00583;PF00611;PF00642;PF00688;PF01302;PF01585;PF02181;PF03165;PF06367;PF06371;PF07651;PF07679;PF14259
Group	GO:0050890	cognition	2	3.69	1.36e-03	4.38e-03	12|275|58|3527	PF00057;PF00122;PF00564;PF00689;PF00690;PF00702;PF01699;PF02177;PF07653;PF12924;PF13639;PF13716
Group	GO:0040029	regulation of gene expression, epigenetic	2	3.59	1.37e-03	4.38e-03	15|275|82|3527	PF00179;PF00270;PF00271;PF00385;PF00400;PF01088;PF01426;PF02008;PF04408;PF05033;PF06464;PF08210;PF12047;PF12796;PF13086
Group	GO:0006952	defense response	2	3.38	1.41e-03	4.46e-03	26|275|181|3527	PF00020;PF00057;PF00059;PF00085;PF00130;PF00240;PF00270;PF00271;PF00350;PF00501;PF00605;PF00969;PF01033;PF01302;PF01391;PF01476;PF01909;PF02263;PF02865;PF05790;PF07534;PF07686;PF10409;PF12697;PF13639;PF13855
Group	GO:0001738	morphogenesis of a polarized epithelium	2	3.87	1.58e-03	5.00e-03	8|275|30|3527	PF00053;PF00063;PF00130;PF00168;PF00564;PF00651;PF06297;PF10608
Group	GO:0036075	replacement ossification	2	4.05	1.77e-03	5.42e-03	6|275|18|3527	PF00019;PF00052;PF00053;PF00057;PF00688;PF07679
Group	GO:0060560	developmental growth involved in morphogenesis	2	3.56	1.86e-03	5.65e-03	12|275|60|3527	PF00019;PF00057;PF00130;PF00688;PF01391;PF02177;PF07653;PF07679;PF08736;PF12796;PF12924;PF13855
Group	GO:0015672	monovalent inorganic cation transport	2	3.56	1.86e-03	5.65e-03	12|275|60|3527	PF00027;PF00153;PF00651;PF00690;PF00702;PF01496;PF01699;PF02214;PF07686;PF07690;PF07707;PF13637
Group	GO:0072347	response to anesthetic	2	4.46	1.97e-03	5.75e-03	4|275|8|3527	PF00052;PF00053;PF00057;PF07679
Group	GO:0045199	maintenance of epithelial cell apical/basal polarity	2	4.46	1.97e-03	5.75e-03	4|275|8|3527	PF00052;PF00053;PF00057;PF07679
Group	GO:0045165	cell fate commitment	2	3.34	2.17e-03	6.21e-03	17|275|103|3527	PF00019;PF00076;PF00130;PF00307;PF00349;PF00435;PF00564;PF00651;PF00688;PF00989;PF01465;PF01562;PF03165;PF07645;PF07653;PF07679;PF10409
Group	GO:0030001	metal ion transport	2	3.29	2.19e-03	6.25e-03	20|275|130|3527	PF00027;PF00085;PF00122;PF00153;PF00168;PF00254;PF00622;PF00651;PF00689;PF00690;PF00702;PF01699;PF01833;PF02214;PF02225;PF04389;PF07686;PF07690;PF07707;PF12796
Group	GO:0009100	glycoprotein metabolic process	2	3.38	2.24e-03	6.37e-03	15|275|86|3527	PF00085;PF00094;PF00122;PF00515;PF00534;PF00535;PF00702;PF00884;PF01841;PF02434;PF04810;PF09409;PF12548;PF13733;PF13855
Group	GO:0009617	response to bacterium	2	3.33	2.35e-03	6.66e-03	16|275|95|3527	PF00020;PF00059;PF00130;PF00168;PF00258;PF00605;PF00667;PF00969;PF01033;PF01302;PF01476;PF02263;PF02865;PF07534;PF12796;PF13855
Group	GO:0040017	positive regulation of locomotion	2	3.47	2.45e-03	6.84e-03	11|275|54|3527	PF00019;PF00053;PF00093;PF00130;PF00168;PF00169;PF00373;PF00688;PF01562;PF07679;PF08246
Group	GO:0016311	dephosphorylation	2	3.47	2.73e-03	7.59e-03	10|275|47|3527	PF00149;PF00373;PF00702;PF04818;PF07679;PF08736;PF09379;PF09380;PF10409;PF13344
Group	GO:0045765	regulation of angiogenesis	2	3.39	3.22e-03	8.63e-03	10|275|48|3527	PF00093;PF00130;PF00168;PF00169;PF00884;PF02865;PF07645;PF08246;PF12548;PF13716
Group	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	2	3.30	3.29e-03	8.63e-03	12|275|64|3527	PF00020;PF00130;PF00168;PF00169;PF00307;PF00564;PF00899;PF01302;PF01392;PF12796;PF13405;PF13855
Group	GO:0034220	ion transmembrane transport	2	3.30	3.29e-03	8.63e-03	12|275|64|3527	PF00027;PF00122;PF00153;PF00452;PF00622;PF00690;PF00702;PF01699;PF02214;PF07686;PF12710;PF12796
Group	GO:0051046	regulation of secretion	2	3.19	3.26e-03	8.63e-03	16|275|98|3527	PF00019;PF00020;PF00027;PF00040;PF00059;PF00097;PF00168;PF00169;PF00349;PF00618;PF00622;PF00688;PF00969;PF01833;PF02214;PF07686
Group	GO:0006518	peptide metabolic process	2	3.40	3.54e-03	9.14e-03	9|275|41|3527	PF00082;PF00501;PF00557;PF00975;PF01433;PF01546;PF04389;PF07687;PF08246
Group	GO:0009991	response to extracellular stimulus	2	3.11	3.61e-03	9.32e-03	18|275|117|3527	PF00019;PF00027;PF00082;PF00149;PF00400;PF00501;PF00564;PF00618;PF00622;PF00688;PF00899;PF01392;PF02518;PF02824;PF02865;PF05773;PF08246;PF10409
Group	GO:0060485	mesenchyme development	2	3.26	3.83e-03	9.84e-03	11|275|57|3527	PF00019;PF00688;PF00754;PF00757;PF01030;PF01392;PF01403;PF01833;PF02865;PF07645;PF07679
Group	GO:0051017	actin filament bundle assembly	3	7.32	1.43e-07	1.82e-06	12|275|26|3527	PF00063;PF00307;PF00373;PF00611;PF02181;PF02214;PF06367;PF06371;PF07653;PF09379;PF09380;PF12796
Group	GO:0002028	regulation of sodium ion transport	3	7.24	6.59e-07	7.33e-06	9|275|16|3527	PF00122;PF00168;PF00169;PF00307;PF00435;PF00689;PF00690;PF00702;PF13405
Group	GO:0045639	positive regulation of myeloid cell differentiation	3	6.90	2.46e-06	2.24e-05	8|275|14|3527	PF00019;PF00130;PF00168;PF00688;PF02198;PF02865;PF12796;PF13405
Group	GO:0001894	tissue homeostasis	3	6.21	5.19e-06	4.30e-05	10|275|24|3527	PF00059;PF00082;PF00373;PF00452;PF01391;PF07686;PF08246;PF08736;PF09379;PF09380
Group	GO:0045186	zonula adherens assembly	3	6.59	1.46e-05	1.07e-04	6|275|9|3527	PF00130;PF00169;PF00307;PF00435;PF00564;PF07653
Group	GO:0045822	negative regulation of heart contraction	3	6.91	1.56e-05	1.13e-04	5|275|6|3527	PF00122;PF00169;PF00689;PF00690;PF00702
Group	GO:0006901	vesicle coating	3	6.20	1.85e-05	1.32e-04	7|275|13|3527	PF00611;PF00651;PF00928;PF01217;PF01602;PF07651;PF07707
Group	GO:0030336	negative regulation of cell migration	3	5.62	2.88e-05	1.93e-04	9|275|23|3527	PF00019;PF00086;PF00688;PF00884;PF01391;PF07546;PF10409;PF12548;PF13855
Group	GO:0048840	otolith development	3	6.88	3.62e-05	2.37e-04	4|275|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0032472	Golgi calcium ion transport	3	6.88	3.62e-05	2.37e-04	4|275|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0032468	Golgi calcium ion homeostasis	3	6.88	3.62e-05	2.37e-04	4|275|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0007088	regulation of mitosis	3	5.44	4.30e-05	2.75e-04	9|275|24|3527	PF00019;PF00270;PF00271;PF00515;PF00688;PF02148;PF07679;PF07686;PF12895
Group	GO:0002026	regulation of the force of heart contraction	3	5.79	7.04e-05	4.23e-04	6|275|11|3527	PF00122;PF00169;PF00689;PF00690;PF00702;PF01699
Group	GO:0034311	diol metabolic process	3	5.38	1.01e-04	5.71e-04	7|275|16|3527	PF00019;PF00109;PF00501;PF00688;PF00698;PF02801;PF08659
Group	GO:0018958	phenol-containing compound metabolic process	3	5.19	1.02e-04	5.77e-04	8|275|21|3527	PF00019;PF00109;PF00501;PF00688;PF00698;PF02801;PF04389;PF08659
Group	GO:0030638	polyketide metabolic process	3	5.78	1.28e-04	6.93e-04	5|275|8|3527	PF00109;PF00698;PF02801;PF08242;PF08659
Group	GO:0043516	regulation of DNA damage response, signal transduction by p53 class mediator	3	5.78	1.28e-04	6.93e-04	5|275|8|3527	PF00040;PF00059;PF00270;PF00271;PF01753
Group	GO:0045646	regulation of erythrocyte differentiation	3	5.46	1.32e-04	7.08e-04	6|275|12|3527	PF00019;PF00307;PF00688;PF02198;PF02865;PF12796
Group	GO:0060491	regulation of cell projection assembly	3	5.01	1.50e-04	7.92e-04	8|275|22|3527	PF00063;PF00086;PF00130;PF02181;PF02518;PF06367;PF06371;PF12796
Group	GO:0007309	oocyte axis specification	3	5.14	1.60e-04	8.26e-04	7|275|17|3527	PF00076;PF00130;PF00564;PF00622;PF00651;PF07525;PF14259
Group	GO:0051238	sequestering of metal ion	3	6.02	1.70e-04	8.52e-04	4|275|5|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0055071	manganese ion homeostasis	3	6.02	1.70e-04	8.52e-04	4|275|5|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0042157	lipoprotein metabolic process	3	4.84	2.15e-04	1.03e-03	8|275|23|3527	PF00057;PF00149;PF00534;PF00535;PF01302;PF01663;PF07645;PF12796
Group	GO:0007173	epidermal growth factor receptor signaling pathway	3	4.84	2.15e-04	1.03e-03	8|275|23|3527	PF00019;PF00130;PF00168;PF00169;PF00688;PF00757;PF01030;PF07645
Group	GO:0008542	visual learning	3	5.17	2.29e-04	1.08e-03	6|275|13|3527	PF00122;PF00689;PF00690;PF00702;PF02177;PF12924
Group	GO:0035265	organ growth	3	5.17	2.29e-04	1.08e-03	6|275|13|3527	PF00019;PF00688;PF02891;PF07679;PF12796;PF14324
Group	GO:0022405	hair cycle process	3	4.93	2.44e-04	1.13e-03	7|275|18|3527	PF00019;PF00688;PF00757;PF01030;PF01391;PF01392;PF07679
Group	GO:0032092	positive regulation of protein binding	3	5.35	2.70e-04	1.22e-03	5|275|9|3527	PF00373;PF02434;PF08736;PF09379;PF09380
Group	GO:0032776	DNA methylation on cytosine	3	5.35	2.70e-04	1.22e-03	5|275|9|3527	PF01426;PF02008;PF06464;PF12047;PF12796
Group	GO:0006611	protein export from nucleus	3	5.35	2.70e-04	1.22e-03	5|275|9|3527	PF00019;PF00688;PF03810;PF08389;PF13405
Group	GO:0007565	female pregnancy	3	4.68	3.01e-04	1.33e-03	8|275|24|3527	PF00045;PF00053;PF00413;PF00754;PF01335;PF01471;PF02865;PF07686
Group	GO:0042476	odontogenesis	3	4.73	3.61e-04	1.54e-03	7|275|19|3527	PF00019;PF00373;PF00688;PF01391;PF07679;PF09379;PF09380
Group	GO:0007391	dorsal closure	3	4.73	3.61e-04	1.54e-03	7|275|19|3527	PF00063;PF00373;PF02185;PF08736;PF09379;PF09380;PF12796
Group	GO:0031333	negative regulation of protein complex assembly	3	4.90	3.74e-04	1.57e-03	6|275|14|3527	PF00130;PF00241;PF00307;PF01302;PF02181;PF12796
Group	GO:0051897	positive regulation of protein kinase B signaling cascade	3	4.90	3.74e-04	1.57e-03	6|275|14|3527	PF00019;PF00688;PF00757;PF01030;PF07653;PF12763
Group	GO:0006984	ER-nucleus signaling pathway	3	4.53	4.13e-04	1.71e-03	8|275|25|3527	PF00085;PF00122;PF00226;PF00400;PF00689;PF00690;PF00702;PF13639
Group	GO:0007561	imaginal disc eversion	3	5.96	4.69e-04	1.90e-03	3|275|3|3527	PF00045;PF00413;PF01471
Group	GO:0008624	induction of apoptosis by extracellular signals	3	4.98	5.05e-04	1.99e-03	5|275|10|3527	PF00020;PF00169;PF00307;PF01335;PF07653
Group	GO:0043171	peptide catabolic process	3	4.98	5.05e-04	1.99e-03	5|275|10|3527	PF00082;PF00557;PF01433;PF04389;PF08246
Group	GO:0071766	Actinobacterium-type cell wall biogenesis	3	4.98	5.05e-04	1.99e-03	5|275|10|3527	PF00109;PF00501;PF00698;PF02801;PF08659
Group	GO:0006885	regulation of pH	3	4.55	5.19e-04	2.02e-03	7|275|20|3527	PF00122;PF00400;PF00689;PF00690;PF00702;PF01496;PF13405
Group	GO:0045930	negative regulation of mitotic cell cycle	3	4.55	5.19e-04	2.02e-03	7|275|20|3527	PF00270;PF00271;PF06733;PF07653;PF09058;PF10608;PF13086
Group	GO:0010827	regulation of glucose transport	3	4.66	5.83e-04	2.24e-03	6|275|15|3527	PF00130;PF00168;PF00169;PF01302;PF01391;PF12796
Group	GO:0002831	regulation of response to biotic stimulus	3	4.38	7.27e-04	2.68e-03	7|275|21|3527	PF00130;PF00168;PF01217;PF01602;PF07686;PF12796;PF13855
Group	GO:0051092	positive regulation of NF-kappaB transcription factor activity	3	4.25	7.38e-04	2.70e-03	8|275|27|3527	PF00130;PF00168;PF00169;PF00564;PF00899;PF12796;PF13405;PF13855
Group	GO:0042181	ketone biosynthetic process	3	4.66	8.68e-04	3.05e-03	5|275|11|3527	PF00109;PF00698;PF02801;PF08242;PF08659
Group	GO:0048640	negative regulation of developmental growth	3	4.66	8.68e-04	3.05e-03	5|275|11|3527	PF00019;PF00611;PF00622;PF00688;PF01403
Group	GO:0051568	histone H3-K4 methylation	3	4.66	8.68e-04	3.05e-03	5|275|11|3527	PF00076;PF00400;PF00515;PF00622;PF02008
Group	GO:0042462	eye photoreceptor cell development	3	4.44	8.72e-04	3.05e-03	6|275|16|3527	PF00063;PF00168;PF00415;PF00651;PF08736;PF10409
Group	GO:0035147	branch fusion, open tracheal system	3	4.87	1.05e-03	3.53e-03	4|275|7|3527	PF00307;PF00435;PF07653;PF13855
Group	GO:0006828	manganese ion transport	3	4.87	1.05e-03	3.53e-03	4|275|7|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0031638	zymogen activation	3	4.87	1.05e-03	3.53e-03	4|275|7|3527	PF00045;PF00413;PF01471;PF08246
Group	GO:0050920	regulation of chemotaxis	3	4.24	1.26e-03	4.20e-03	6|275|17|3527	PF00019;PF00688;PF01403;PF01437;PF01833;PF07653
Group	GO:0031331	positive regulation of cellular catabolic process	3	4.24	1.26e-03	4.20e-03	6|275|17|3527	PF00271;PF00400;PF00642;PF00778;PF12697;PF13855
Group	GO:0043900	regulation of multi-organism process	3	4.06	1.34e-03	4.35e-03	7|275|23|3527	PF00130;PF00168;PF00605;PF01217;PF01602;PF12796;PF13855
Group	GO:0030010	establishment of cell polarity	3	4.06	1.34e-03	4.35e-03	7|275|23|3527	PF00130;PF00169;PF00373;PF00400;PF00564;PF01302;PF09379
Group	GO:0046165	alcohol biosynthetic process	3	4.06	1.34e-03	4.35e-03	7|275|23|3527	PF00019;PF00109;PF00205;PF00688;PF00698;PF02801;PF08659
Group	GO:0001935	endothelial cell proliferation	3	4.38	1.39e-03	4.44e-03	5|275|12|3527	PF00019;PF00688;PF07653;PF09058;PF10608
Group	GO:0019954	asexual reproduction	3	4.38	1.39e-03	4.44e-03	5|275|12|3527	PF00063;PF00169;PF00618;PF02518;PF09335
Group	GO:0007435	salivary gland morphogenesis	3	4.05	1.77e-03	5.42e-03	6|275|18|3527	PF01391;PF01403;PF07679;PF07686;PF08736;PF10409
Group	GO:0045807	positive regulation of endocytosis	3	4.05	1.77e-03	5.42e-03	6|275|18|3527	PF00059;PF00168;PF00400;PF01302;PF01391;PF07686
Group	GO:0050796	regulation of insulin secretion	3	3.92	1.77e-03	5.42e-03	7|275|24|3527	PF00019;PF00027;PF00168;PF00349;PF00688;PF00969;PF02214
Group	GO:0000186	activation of MAPKK activity	3	4.46	1.97e-03	5.75e-03	4|275|8|3527	PF00019;PF00688;PF00780;PF07653
Group	GO:0009624	response to nematode	3	4.46	1.97e-03	5.75e-03	4|275|8|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0050886	endocrine process	3	4.46	1.97e-03	5.75e-03	4|275|8|3527	PF00019;PF00688;PF01392;PF01433
Group	GO:0040009	regulation of growth rate	3	4.46	1.97e-03	5.75e-03	4|275|8|3527	PF00133;PF00270;PF00271;PF00989
Group	GO:0033135	regulation of peptidyl-serine phosphorylation	3	4.46	1.97e-03	5.75e-03	4|275|8|3527	PF00019;PF00169;PF00452;PF00688
Group	GO:0032479	regulation of type I interferon production	3	4.46	1.97e-03	5.75e-03	4|275|8|3527	PF00240;PF00271;PF00605;PF13855
Group	GO:0071526	semaphorin-plexin signaling pathway	3	4.46	1.97e-03	5.75e-03	4|275|8|3527	PF00754;PF01403;PF01437;PF01833
Group	GO:0030703	eggshell formation	3	4.46	1.97e-03	5.75e-03	4|275|8|3527	PF00168;PF00385;PF00622;PF07525
Group	GO:0050772	positive regulation of axonogenesis	3	4.46	1.97e-03	5.75e-03	4|275|8|3527	PF01403;PF01437;PF07679;PF13855
Group	GO:0050885	neuromuscular process controlling balance	3	4.13	2.12e-03	6.09e-03	5|275|13|3527	PF00063;PF02177;PF07653;PF12796;PF12924
Group	GO:0030177	positive regulation of Wnt receptor signaling pathway	3	4.13	2.12e-03	6.09e-03	5|275|13|3527	PF00884;PF01391;PF07679;PF12548;PF13639
Group	GO:0018198	peptidyl-cysteine modification	3	4.13	2.12e-03	6.09e-03	5|275|13|3527	PF00258;PF00667;PF00899;PF01302;PF12796
Group	GO:0042177	negative regulation of protein catabolic process	3	4.13	2.12e-03	6.09e-03	5|275|13|3527	PF00240;PF00307;PF00789;PF01335;PF02148
Group	GO:0008105	asymmetric protein localization	3	4.13	2.12e-03	6.09e-03	5|275|13|3527	PF00130;PF00373;PF00564;PF09379;PF09380
Group	GO:0061136	regulation of proteasomal protein catabolic process	3	3.88	2.42e-03	6.77e-03	6|275|19|3527	PF00240;PF00400;PF00515;PF00778;PF00789;PF02148
Group	GO:0032506	cytokinetic process	3	3.88	2.42e-03	6.77e-03	6|275|19|3527	PF00063;PF00169;PF00307;PF02181;PF06367;PF06371
Group	GO:0001649	osteoblast differentiation	3	3.88	2.42e-03	6.77e-03	6|275|19|3527	PF00019;PF00093;PF00688;PF01392;PF03165;PF13716
Group	GO:0042472	inner ear morphogenesis	3	3.65	2.93e-03	8.12e-03	7|275|26|3527	PF00063;PF00122;PF00689;PF00690;PF00702;PF01392;PF07679
Group	GO:0007266	Rho protein signal transduction	3	3.90	3.09e-03	8.46e-03	5|275|14|3527	PF00063;PF00169;PF00435;PF00651;PF02185
Group	GO:0002695	negative regulation of leukocyte activation	3	3.90	3.09e-03	8.46e-03	5|275|14|3527	PF00019;PF00605;PF00651;PF00688;PF00969
Group	GO:0003382	epithelial cell morphogenesis	3	3.90	3.09e-03	8.46e-03	5|275|14|3527	PF00019;PF00024;PF00130;PF00688;PF01392
Group	GO:0030433	ER-associated protein catabolic process	3	3.90	3.09e-03	8.46e-03	5|275|14|3527	PF00085;PF00226;PF05020;PF05021;PF13589
Group	GO:0007589	body fluid secretion	3	4.11	3.33e-03	8.63e-03	4|275|9|3527	PF00122;PF00702;PF01553;PF02865
Group	GO:0051148	negative regulation of muscle cell differentiation	3	4.11	3.33e-03	8.63e-03	4|275|9|3527	PF00019;PF00688;PF12796;PF14259
Group	GO:0048010	vascular endothelial growth factor receptor signaling pathway	3	4.11	3.33e-03	8.63e-03	4|275|9|3527	PF00754;PF00884;PF07686;PF12548
Group	GO:0016339	calcium-dependent cell-cell adhesion	3	4.11	3.33e-03	8.63e-03	4|275|9|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0060571	morphogenesis of an epithelial fold	3	4.11	3.33e-03	8.63e-03	4|275|9|3527	PF00130;PF00757;PF01030;PF07679
Group	GO:0010463	mesenchymal cell proliferation	3	4.11	3.33e-03	8.63e-03	4|275|9|3527	PF00019;PF00688;PF02865;PF07679
Group	GO:0007176	regulation of epidermal growth factor-activated receptor activity	3	4.11	3.33e-03	8.63e-03	4|275|9|3527	PF01585;PF02177;PF07525;PF12924
Group	GO:0007157	heterophilic cell-cell adhesion	3	4.11	3.33e-03	8.63e-03	4|275|9|3527	PF00059;PF07679;PF07686;PF13855
Group	GO:0075136	response to host	3	4.11	3.33e-03	8.63e-03	4|275|9|3527	PF00019;PF00501;PF00688;PF13855
Group	GO:0048009	insulin-like growth factor receptor signaling pathway	3	4.11	3.33e-03	8.63e-03	4|275|9|3527	PF00169;PF00757;PF01030;PF02145
Group	GO:0051653	spindle localization	3	4.11	3.33e-03	8.63e-03	4|275|9|3527	PF00063;PF00400;PF00515;PF01302
Group	GO:0045931	positive regulation of mitotic cell cycle	3	3.71	3.23e-03	8.63e-03	6|275|20|3527	PF00130;PF00168;PF01426;PF02177;PF02865;PF12924
Group	GO:0097040	phthiocerol biosynthetic process	4	6.02	1.70e-04	8.52e-04	4|275|5|3527	PF00109;PF00698;PF02801;PF08659
Group	GO:0097041	phenolic phthiocerol biosynthetic process	4	6.02	1.70e-04	8.52e-04	4|275|5|3527	PF00109;PF00698;PF02801;PF08659
Group	GO:0045648	positive regulation of erythrocyte differentiation	4	6.02	1.70e-04	8.52e-04	4|275|5|3527	PF00019;PF00688;PF02198;PF12796
Group	GO:0040021	hermaphrodite germ-line sex determination	4	5.96	4.69e-04	1.90e-03	3|275|3|3527	PF00076;PF00270;PF00271
Group	GO:0090191	negative regulation of branching involved in ureteric bud morphogenesis	4	5.96	4.69e-04	1.90e-03	3|275|3|3527	PF00019;PF00086;PF00688
Group	GO:0007183	SMAD protein complex assembly	4	5.01	1.77e-03	5.42e-03	3|275|4|3527	PF00019;PF00688;PF03165
Group	GO:0010216	maintenance of DNA methylation	4	5.01	1.77e-03	5.42e-03	3|275|4|3527	PF00271;PF01426;PF12047
Group	GO:0030574	collagen catabolic process	4	5.01	1.77e-03	5.42e-03	3|275|4|3527	PF00045;PF00413;PF01471
Group	GO:0031145	anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process	4	5.01	1.77e-03	5.42e-03	3|275|4|3527	PF00179;PF00515;PF12895
